| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NR2F6 CDX2 ZBTB38 IRX5 SALL3 ESR1 SOX8 ZNF236 FOXI3 FOXA2 MEF2D HOXA6 SALL1 NLRC5 PLAGL1 HSF1 HSF4 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 EBF3 POU2F2 CHD7 POU5F1 HIF3A SIRT1 MSX1 FOXD3 EGR1 MTF1 MZF1 ZFHX2 ZFHX3 PAX9 NPAS4 | 4.47e-09 | 1271 | 228 | 40 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NR2F6 CDX2 ZBTB38 IRX5 SALL3 ESR1 SOX8 ZNF236 FOXI3 FOXA2 MEF2D HOXA6 SALL1 NLRC5 PLAGL1 HSF1 HSF4 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 EBF3 POU2F2 CHD7 POU5F1 HIF3A SIRT1 FOXD3 EGR1 MTF1 MZF1 ZFHX2 ZFHX3 PAX9 NPAS4 | 8.01e-09 | 1244 | 228 | 39 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NR2F6 CDX2 ZBTB38 IRX5 SALL3 ESR1 SOX8 ZNF236 FOXI3 FOXA2 MEF2D HOXA6 SALL1 HOXD12 PLAGL1 HSF1 HSF4 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 DBX2 EBF3 POU2F2 POU5F1 HIF3A MSX1 FOXD3 KMT2D EGR1 MTF1 MZF1 ZFHX2 ZFHX3 PAX9 NPAS4 | 8.07e-08 | 1412 | 228 | 40 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NR2F6 CDX2 ZBTB38 IRX5 SALL3 ESR1 SOX8 ZNF236 FOXI3 FOXA2 MEF2D HOXA6 SALL1 NLRC5 PLAGL1 HSF1 HSF4 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 EBF3 POU2F2 CHD7 POU5F1 HIF3A SIRT1 MSX1 FOXD3 EGR1 MTF1 MZF1 ZFHX2 ZFHX3 PAX9 NPAS4 | 1.92e-07 | 1459 | 228 | 40 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 5.03e-07 | 27 | 228 | 6 | GO:0008139 | |
| GeneOntologyMolecularFunction | chromatin binding | MTA2 LEMD3 ESR1 MBD6 FOXA2 AHDC1 TNRC18 SCML2 SALL1 MLLT6 HSF1 MBD2 TAL1 VAX1 TCF3 EP400 CHD7 POU5F1 SIRT1 EGR1 TRIM28 PRDM13 SMARCC2 HR | 4.35e-06 | 739 | 228 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 8.19e-06 | 25 | 228 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | NR2F6 CDX2 SALL1 PLAGL1 HSF1 HSF4 TBX2 VAX1 TCF3 POU5F1 MSX1 FOXD3 MZF1 ZFHX3 | 2.00e-05 | 320 | 228 | 14 | GO:0001227 |
| GeneOntologyMolecularFunction | signal sequence binding | 2.43e-05 | 51 | 228 | 6 | GO:0005048 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | NR2F6 CDX2 SALL1 PLAGL1 HSF1 HSF4 TBX2 VAX1 TCF3 POU5F1 MSX1 FOXD3 MZF1 ZFHX3 | 2.46e-05 | 326 | 228 | 14 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ESR1 FOXA2 MEF2D PLAGL1 HSF1 HSF4 FOXF2 EBF4 TCF3 EBF3 POU2F2 POU5F1 MSX1 KMT2D EGR1 MTF1 MZF1 PAX9 NPAS4 | 2.50e-05 | 560 | 228 | 19 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ESR1 FOXA2 MEF2D PLAGL1 HSF1 HSF4 FOXF2 EBF4 TCF3 EBF3 POU2F2 POU5F1 MSX1 KMT2D EGR1 MTF1 MZF1 PAX9 NPAS4 | 2.90e-05 | 566 | 228 | 19 | GO:0001216 |
| GeneOntologyMolecularFunction | disaccharide binding | 4.97e-05 | 7 | 228 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.17e-04 | 9 | 228 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.32e-04 | 167 | 228 | 9 | GO:0031490 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MTA2 IRX5 ESR1 ZFPM1 SOX8 MEF2D SALL1 HSF1 TAL1 EBF4 TBX2 TCF3 TACC2 POU5F1 RFC1 SIRT1 PRDM13 HR | 1.33e-04 | 582 | 228 | 18 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription factor binding | MTA2 IRX5 PPRC1 ESR1 ZFPM1 SOX8 FOXA2 MEF2D SALL1 HSF1 TAL1 FOXF2 EBF4 TBX2 TCF3 TACC2 POU5F1 RFC1 SIRT1 PRDM13 HR | 1.56e-04 | 753 | 228 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coactivator activity | MTA2 PPRC1 VGLL2 ZMIZ2 MAML3 VGLL1 MAGED1 TCF20 SIRT1 KMT2D TRIM28 SMARCC2 | 2.00e-04 | 303 | 228 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | MTA2 SUPT20HL1 PPRC1 VGLL2 ZFPM1 ZMIZ2 MAML3 VGLL1 MAGED1 TCF20 LIMD1 PARP14 SIRT1 KMT2D TRIM28 SMARCC2 HR | 2.65e-04 | 562 | 228 | 17 | GO:0003712 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.76e-04 | 83 | 228 | 6 | GO:1990841 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 3.86e-04 | 13 | 228 | 3 | GO:0001162 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MTA2 SUPT20HL1 ZSWIM8 PPRC1 VGLL2 ZFPM1 ATG2A ZMIZ2 SLA2 MAML3 VGLL1 MAGED1 TCF20 LIMD1 PARP14 SIRT1 IGF2BP1 KMT2D ABI2 TRIM28 MDC1 SMARCC2 AKAP13 YTHDF3 GAB1 HR | 7.94e-04 | 1160 | 228 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 8.88e-04 | 17 | 228 | 3 | GO:0001161 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | MTA2 ESR1 ZFPM1 MEF2D SALL1 HSF1 TAL1 TCF3 TACC2 POU5F1 SIRT1 PRDM13 HR | 1.06e-03 | 417 | 228 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.45e-03 | 20 | 228 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MTA2 SUPT20HL1 ZSWIM8 PPRC1 VGLL2 ZFPM1 ATG2A AHDC1 ZMIZ2 SLA2 MBD2 MAML3 VGLL1 MAGED1 TCF20 LIMD1 PARP14 SIRT1 IGF2BP1 KMT2D ABI2 TRIM28 MDC1 SMARCC2 AKAP13 YTHDF3 GAB1 HR | 1.72e-03 | 1356 | 228 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 1.89e-03 | 6 | 228 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | acetylesterase activity | 1.89e-03 | 6 | 228 | 2 | GO:0008126 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MTA2 SUPT20HL1 CDX2 ZBTB38 SETX PPRC1 VGLL2 ESR1 ZFPM1 SOX8 FOXA2 MEF2D RPRD1B ZNF462 SALL1 ZMIZ2 NLRC5 PLAGL1 MLLT6 HSF1 TAL1 MAML3 NOTCH3 FOXF2 EBF4 TBX2 TCF3 TCF20 EBF3 POU2F2 CHD7 POU5F1 HIF3A SIRT1 MSX1 FOXD3 KMT2D EGR1 MTF1 MZF1 MDC1 ZFHX3 TNKS PAX9 NPAS4 | 4.11e-11 | 1390 | 226 | 45 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MTA2 NR2F6 CDX2 ZBTB38 TRO ESR1 ZFPM1 SOX8 SCML2 SALL1 PLAGL1 SLA2 HSF1 HSF4 MBD2 TAL1 NOTCH3 FOXF2 TBX2 VAX1 TCF3 MAGED1 LIMD1 POU5F1 RFC1 PARP14 SIRT1 LEFTY2 MSX1 LEFTY1 FOXD3 EGR1 MZF1 TRIM28 PRDM13 SMARCC2 ZFHX3 PAX9 PRDM6 HR | 2.04e-08 | 1399 | 226 | 40 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MTA2 NR2F6 CDX2 ZBTB38 TRO ESR1 ZFPM1 SOX8 SCML2 SALL1 PLAGL1 SLA2 HSF1 HSF4 MBD2 TAL1 NOTCH3 FOXF2 TBX2 VAX1 TCF3 MAGED1 LIMD1 POU5F1 RFC1 PARP14 SIRT1 LEFTY2 MSX1 LEFTY1 FOXD3 EGR1 MZF1 TRIM28 PRDM13 SMARCC2 ZFHX3 PAX9 PRDM6 HR | 2.69e-08 | 1413 | 226 | 40 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MTA2 NR2F6 CDX2 TRO ESR1 ZFPM1 SOX8 SALL1 PLAGL1 SLA2 HSF1 HSF4 MBD2 TAL1 NOTCH3 TBX2 VAX1 TCF3 MAGED1 POU5F1 RFC1 SIRT1 LEFTY2 MSX1 LEFTY1 FOXD3 EGR1 MZF1 TRIM28 PRDM13 SMARCC2 ZFHX3 PRDM6 | 5.11e-08 | 1053 | 226 | 33 | GO:0000122 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | GAK CDX2 IRX5 ESR1 ZFPM1 SOX8 FOXI3 FOXA2 AHDC1 MEF2D SALL1 ACAN AMTN FOXF2 TBX2 TBX4 MAGED1 SOBP FLVCR1 WNT9B PCDHA12 DUOX2 PCDHA10 CHD7 IDUA TSKU LEFTY2 MSX1 COL18A1 LEFTY1 MEGF8 ABI2 DCHS1 ELN PAX9 CRB2 | 1.41e-07 | 1269 | 226 | 36 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic organ development | CDX2 IRX5 SPINT1 ZFPM1 SALL1 HSF1 MBD2 TAL1 FOXF2 TBX2 TBX4 SOBP FLVCR1 WNT9B CHD7 MSX1 COL18A1 FOXD3 MEGF8 TRIM28 GAB1 CRB2 | 2.64e-07 | 561 | 226 | 22 | GO:0048568 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SUPT20HL1 IRX5 SPINT1 SOX8 FOXA2 AHDC1 SALL1 HOXD12 TAL1 FOXF2 TBX2 CACNA1C TCF3 TBX4 SOBP FLVCR1 WNT9B CHD7 POU5F1 LEFTY2 MSX1 LEFTY1 MEGF8 TRIM28 CRB2 | 3.21e-07 | 713 | 226 | 25 | GO:0048598 |
| GeneOntologyBiologicalProcess | embryo development | SUPT20HL1 CDX2 IRX5 SPINT1 ZFPM1 SOX8 FOXI3 FOXA2 AHDC1 HOXA6 SALL1 HOXD12 HSF1 MBD2 TAL1 FOXF2 TBX2 CACNA1C TCF3 TBX4 SOBP FLVCR1 WNT9B CHD7 POU5F1 LEFTY2 MSX1 COL18A1 LEFTY1 FOXD3 KMT2D MEGF8 TRIM28 DCHS1 GAB1 CRB2 | 2.68e-06 | 1437 | 226 | 36 | GO:0009790 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 5.15e-06 | 4 | 226 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | SALL3 SALL1 HOXD12 TBX2 CACNA1C TBX4 FLVCR1 CHD7 IDUA MSX1 MEGF8 | 6.49e-06 | 185 | 226 | 11 | GO:0035107 |
| GeneOntologyBiologicalProcess | limb morphogenesis | SALL3 SALL1 HOXD12 TBX2 CACNA1C TBX4 FLVCR1 CHD7 IDUA MSX1 MEGF8 | 6.49e-06 | 185 | 226 | 11 | GO:0035108 |
| GeneOntologyBiologicalProcess | circulatory system development | CDX2 SPINT1 LEMD3 PAK4 ZFPM1 SALL1 MYLK3 AP1B1 ACAN MBD2 TAL1 NOTCH3 FOXL1 TBX2 CACNA1C TBX4 FLVCR1 PCDHA12 PCDHA10 CHD7 HIF3A SIRT1 LEFTY2 MSX1 COL18A1 LEFTY1 MEGF8 EGR1 CSPG4 DCHS1 MMRN2 AKAP13 ELN GAB1 CRB2 | 7.52e-06 | 1442 | 226 | 35 | GO:0072359 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SPINT1 ESR1 ZFPM1 SOX8 FOXA2 AHDC1 SALL1 TAL1 FOXF2 FOXL1 TBX2 TBX4 MAGED1 WNT9B FIGNL2 CHD7 POU5F1 MSX1 MEGF8 TRIM28 DCHS1 MMRN2 CRB2 | 9.06e-06 | 750 | 226 | 23 | GO:0048729 |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 1.15e-05 | 97 | 226 | 8 | GO:0006029 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 3.81e-05 | 148 | 226 | 9 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 3.81e-05 | 148 | 226 | 9 | GO:0035113 | |
| GeneOntologyBiologicalProcess | limb development | SALL3 SALL1 HOXD12 TBX2 CACNA1C TBX4 FLVCR1 CHD7 IDUA MSX1 MEGF8 | 3.87e-05 | 224 | 226 | 11 | GO:0060173 |
| GeneOntologyBiologicalProcess | appendage development | SALL3 SALL1 HOXD12 TBX2 CACNA1C TBX4 FLVCR1 CHD7 IDUA MSX1 MEGF8 | 3.87e-05 | 224 | 226 | 11 | GO:0048736 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | LGALS9C LGALS9B TRO LRFN3 ICAM1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 LGALS9 NPTN DCHS1 CRB2 | 4.46e-05 | 313 | 226 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 4.78e-05 | 19 | 226 | 4 | GO:1900426 | |
| GeneOntologyBiologicalProcess | cell migration involved in gastrulation | 5.92e-05 | 20 | 226 | 4 | GO:0042074 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 6.53e-05 | 63 | 226 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 6.98e-05 | 8 | 226 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | heart development | ZFPM1 SALL1 MYLK3 AP1B1 ACAN MBD2 FOXL1 TBX2 CACNA1C PCDHA12 PCDHA10 CHD7 SIRT1 LEFTY2 MSX1 LEFTY1 MEGF8 DCHS1 AKAP13 ELN GAB1 | 9.52e-05 | 757 | 226 | 21 | GO:0007507 |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 1.20e-04 | 2 | 226 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 1.20e-04 | 2 | 226 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 1.20e-04 | 2 | 226 | 2 | GO:1900123 | |
| GeneOntologyBiologicalProcess | gastrulation | SUPT20HL1 FOXA2 AHDC1 TAL1 TCF3 POU5F1 LEFTY2 LEFTY1 MEGF8 CRB2 | 1.21e-04 | 212 | 226 | 10 | GO:0007369 |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 1.61e-04 | 74 | 226 | 6 | GO:0042733 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 1.74e-04 | 26 | 226 | 4 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of an epithelium | 1.87e-04 | 76 | 226 | 6 | GO:1905330 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 1.95e-04 | 49 | 226 | 5 | GO:0035137 | |
| GeneOntologyBiologicalProcess | head development | GAK SALL3 KIF26A SSTR3 FOXA2 SALL1 SEC16A NOTCH3 VAX1 DNAJC30 FLVCR1 WNT9B DUOX2 TACC2 CHD7 GRIN2D TSKU MSX1 IGF2BP1 AATK PRDM13 PAX9 MYO16 | 2.02e-04 | 919 | 226 | 23 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.63e-04 | 114 | 226 | 7 | GO:0045824 | |
| GeneOntologyBiologicalProcess | central nervous system development | GAK SALL3 KIF26A SOX8 SSTR3 FOXA2 SALL1 ACAN SEC16A TAL1 NOTCH3 NOVA2 VAX1 DNAJC30 WNT9B DUOX2 TACC2 CHD7 GRIN2D TSKU MSX1 IGF2BP1 AATK MTF1 PRDM13 DUSP10 MYO16 | 3.01e-04 | 1197 | 226 | 27 | GO:0007417 |
| GeneOntologyBiologicalProcess | muscle organ development | LEMD3 VGLL2 ZFPM1 SOX8 MEF2D PLAGL1 COL6A3 VAX1 CHD7 SIRT1 MSX1 EGR1 ZFHX3 ELN | 3.42e-04 | 436 | 226 | 14 | GO:0007517 |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 3.50e-04 | 31 | 226 | 4 | GO:0045591 | |
| GeneOntologyBiologicalProcess | Golgi to secretory granule transport | 3.56e-04 | 3 | 226 | 2 | GO:0055107 | |
| GeneOntologyBiologicalProcess | cell fate commitment | MTA2 ZFPM1 SOX8 FOXI3 FOXA2 TAL1 NOTCH3 TBX2 TCF3 TBX4 WNT9B POU5F1 | 3.73e-04 | 338 | 226 | 12 | GO:0045165 |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 3.97e-04 | 32 | 226 | 4 | GO:1903306 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | CDX2 IRX5 SPINT1 SOX8 FOXI3 FOXA2 HOXA6 SALL1 HSF1 TBX2 FLVCR1 WNT9B CHD7 POU5F1 MSX1 FOXD3 KMT2D MEGF8 TRIM28 DCHS1 GAB1 CRB2 | 4.21e-04 | 906 | 226 | 22 | GO:0043009 |
| GeneOntologyBiologicalProcess | cardiac chamber formation | 4.32e-04 | 14 | 226 | 3 | GO:0003207 | |
| GeneOntologyBiologicalProcess | muscle tissue development | LEMD3 VGLL2 ZFPM1 SOX8 MEF2D MYLK3 PLAGL1 MBD2 TBX2 VAX1 CHD7 SIRT1 MSX1 EGR1 AKAP13 ELN | 4.59e-04 | 558 | 226 | 16 | GO:0060537 |
| GeneOntologyBiologicalProcess | cellular response to virus | 4.69e-04 | 90 | 226 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | brain development | GAK SALL3 KIF26A SSTR3 FOXA2 SALL1 SEC16A NOTCH3 VAX1 DNAJC30 WNT9B DUOX2 TACC2 CHD7 GRIN2D TSKU MSX1 IGF2BP1 AATK PRDM13 MYO16 | 5.22e-04 | 859 | 226 | 21 | GO:0007420 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 5.36e-04 | 15 | 226 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 5.36e-04 | 15 | 226 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.82e-04 | 258 | 226 | 10 | GO:0001763 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | CDX2 IRX5 SPINT1 SOX8 FOXI3 FOXA2 HOXA6 SALL1 HSF1 TBX2 FLVCR1 WNT9B CHD7 POU5F1 MSX1 FOXD3 KMT2D MEGF8 TRIM28 DCHS1 GAB1 CRB2 | 5.89e-04 | 929 | 226 | 22 | GO:0009792 |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 6.61e-04 | 96 | 226 | 6 | GO:0035914 | |
| GeneOntologyBiologicalProcess | nephron development | 6.85e-04 | 174 | 226 | 8 | GO:0072006 | |
| GeneOntologyBiologicalProcess | astrocyte fate commitment | 7.07e-04 | 4 | 226 | 2 | GO:0060018 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 7.07e-04 | 4 | 226 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | RNA transport | 7.11e-04 | 175 | 226 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 7.11e-04 | 175 | 226 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | epithelium development | GAK CDX2 SPINT1 AQP11 ESR1 SOX8 FOXI3 FOXA2 SALL1 HSD17B4 HSF4 FOXF2 TBX2 VAX1 TBX4 MAGED1 ICAM1 WNT9B FIGNL2 CHD7 MSX1 COL18A1 MEGF8 ABI2 TRIM28 DCHS1 MMRN2 DUSP10 PRLR CRB2 | 7.23e-04 | 1469 | 226 | 30 | GO:0060429 |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 7.73e-04 | 38 | 226 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | metanephric nephron development | 7.73e-04 | 38 | 226 | 4 | GO:0072210 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 7.88e-04 | 17 | 226 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.95e-04 | 178 | 226 | 8 | GO:0051236 | |
| GeneOntologyCellularComponent | chromatin | MTA2 SUPT20HL1 NR2F6 CDX2 IRX5 ESR1 ZFPM1 SOX8 FOXA2 MEF2D HOXA6 SCML2 SALL1 HOXD12 ZMIZ2 HSF1 HSF4 MBD2 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 MAGED1 EP400 DBX2 EBF3 BICRA POU2F2 CHD7 POU5F1 HIF3A SIRT1 MSX1 FOXD3 EGR1 TRIM28 VRTN ZFHX2 SMARCC2 ZFHX3 PAX9 NPAS4 HR | 3.22e-11 | 1480 | 230 | 47 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | MTA2 CDX2 ESR1 ZFPM1 SOX8 FOXA2 SALL1 HOXD12 MBD2 TAL1 FOXF2 TBX2 TCF3 LIMD1 POU5F1 MSX1 FOXD3 TRIM28 ZFHX3 PAX9 NPAS4 | 2.96e-06 | 596 | 230 | 21 | GO:0005667 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 6.76e-04 | 96 | 230 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | CHD-type complex | 7.98e-04 | 17 | 230 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 7.98e-04 | 17 | 230 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | nuclear pore | 8.83e-04 | 101 | 230 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | P-body | 9.29e-04 | 102 | 230 | 6 | GO:0000932 | |
| GeneOntologyCellularComponent | nuclear body | SETX ANKS1B CWC25 HOXA6 PLAGL1 HSF1 HSF4 MAML3 FOXF2 TCF20 EP400 C11orf54 RANBP9 HIF3A SIRT1 PRCC MDC1 UHMK1 ZFHX3 TNKS HR | 1.04e-03 | 903 | 230 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | euchromatin | 1.19e-03 | 72 | 230 | 5 | GO:0000791 | |
| MousePheno | abnormal tricuspid valve morphology | 2.30e-05 | 26 | 190 | 5 | MP:0002624 | |
| MousePheno | absent palatine bone horizontal plate | 2.98e-05 | 14 | 190 | 4 | MP:0000431 | |
| MousePheno | abnormal palate morphology | SALL3 MBD6 FOXI3 ACAN MN1 FOXF2 TBX2 VAX1 WNT9B CHD7 SIRT1 MSX1 MEGF8 PAX9 GAB1 | 3.31e-05 | 321 | 190 | 15 | MP:0003755 |
| MousePheno | abnormal hard palate morphology | 3.35e-05 | 67 | 190 | 7 | MP:0003756 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 3.35e-05 | 28 | 190 | 5 | MP:0004537 | |
| MousePheno | abnormal palatine bone morphology | 3.47e-05 | 46 | 190 | 6 | MP:0005249 | |
| MousePheno | abnormal maxillary shelf morphology | 4.01e-05 | 29 | 190 | 5 | MP:0004538 | |
| MousePheno | abnormal atrioventricular valve morphology | 4.06e-05 | 69 | 190 | 7 | MP:0002745 | |
| MousePheno | abnormal secondary palate morphology | 6.28e-05 | 159 | 190 | 10 | MP:0013550 | |
| MousePheno | abnormal heart atrium and ventricle connection | 6.98e-05 | 75 | 190 | 7 | MP:0010435 | |
| MousePheno | abnormal heart valve morphology | PCDHA12 PCDHA10 IDUA SIRT1 LEFTY2 COL18A1 LEFTY1 MEGF8 DCHS1 ELN | 7.74e-05 | 163 | 190 | 10 | MP:0000285 |
| MousePheno | abnormal cardiovascular development | SUPT20HL1 LEMD3 ZFPM1 FOXA2 AHDC1 TAL1 NOTCH3 TBX2 CACNA1C TBX4 DYNC2I2 FLVCR1 ICAM1 CHD7 SIRT1 LEFTY2 LEFTY1 MEGF8 VRTN MMRN2 AKAP13 ELN PAX9 PRDM6 CRB2 | 8.78e-05 | 802 | 190 | 25 | MP:0002925 |
| MousePheno | abnormal embryonic tissue morphology | SUPT20HL1 PPRC1 ESR1 PAK4 MBD6 FOXI3 FOXA2 BRAP PLAGL1 TAL1 TBX2 CACNA1C VAX1 TBX4 EP400 DYNC2I2 WNT9B DOLK CHD7 SIRT1 LEFTY2 MSX1 LEFTY1 FOXD3 EGR1 TRIM28 DCHS1 VRTN AKAP13 PAX9 CRB2 | 1.02e-04 | 1116 | 190 | 31 | MP:0002085 |
| MousePheno | abnormal palatal shelf fusion at midline | 1.06e-04 | 80 | 190 | 7 | MP:0009887 | |
| MousePheno | increased T-helper 1 cell number | 1.09e-04 | 19 | 190 | 4 | MP:0008086 | |
| MousePheno | abnormal heart size | ZSWIM8 GAK SALL3 ESR1 ZFPM1 ZNF236 MYLK3 NRXN2 ACAN PLAGL1 ALDH2 HSD17B4 HSF4 TAL1 NOTCH3 CACNA1C BICRA FLVCR1 PCDHA12 DUOX2 PCDHA10 GRIN2D IDUA SIRT1 MSX1 NPTN MEGF8 AKAP13 TNKS ELN UBE3C GAB1 | 1.21e-04 | 1180 | 190 | 32 | MP:0005406 |
| MousePheno | abnormal vascular development | SUPT20HL1 LEMD3 ZFPM1 AHDC1 TAL1 NOTCH3 TBX2 CACNA1C TBX4 FLVCR1 ICAM1 CHD7 LEFTY2 LEFTY1 MMRN2 ELN PAX9 PRDM6 CRB2 | 1.50e-04 | 542 | 190 | 19 | MP:0000259 |
| MousePheno | cleft palate | MBD6 FOXI3 ACAN MN1 FOXF2 TBX2 VAX1 WNT9B CHD7 MSX1 MEGF8 PAX9 GAB1 | 1.63e-04 | 289 | 190 | 13 | MP:0000111 |
| MousePheno | abnormal pterygoid process morphology | 1.65e-04 | 21 | 190 | 4 | MP:0004452 | |
| MousePheno | oral cleft | MBD6 FOXI3 ACAN MN1 FOXF2 TBX2 VAX1 WNT9B CHD7 MSX1 MEGF8 PAX9 GAB1 | 1.75e-04 | 291 | 190 | 13 | MP:0021164 |
| MousePheno | increased collagen deposition in the muscles | 1.84e-04 | 2 | 190 | 2 | MP:0000731 | |
| MousePheno | abnormal left renal vein morphology | 1.84e-04 | 2 | 190 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 1.84e-04 | 2 | 190 | 2 | MP:0011323 | |
| MousePheno | accessory spleen | 1.95e-04 | 9 | 190 | 3 | MP:0003342 | |
| MousePheno | neonatal lethality | ZSWIM8 GAK SALL3 TNRC6B FOXI3 FOXA2 FAH SALL1 ACAN PLAGL1 MN1 FOXF2 CACNA1C VAX1 TCF3 EBF3 WNT9B RANBP9 POU2F2 SIRT1 MSX1 SMARCC2 PAX9 CMTM7 | 2.15e-04 | 799 | 190 | 24 | MP:0002058 |
| MousePheno | abnormal palatal shelf morphology | 2.44e-04 | 121 | 190 | 8 | MP:0031460 | |
| MousePheno | abnormal T-helper 1 cell number | 2.84e-04 | 24 | 190 | 4 | MP:0008085 | |
| MousePheno | abnormal secondary palate development | 2.89e-04 | 124 | 190 | 8 | MP:0009655 | |
| MousePheno | failure of chorioallantoic fusion | 2.92e-04 | 67 | 190 | 6 | MP:0009657 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | ZFPM1 FOXI3 SALL1 TBX2 DYNC2I2 FLVCR1 CHD7 SIRT1 LEFTY2 LEFTY1 PRDM6 GAB1 | 3.04e-04 | 268 | 190 | 12 | MP:0011108 |
| MousePheno | abnormal lymph node secondary follicle morphology | 3.34e-04 | 25 | 190 | 4 | MP:0002346 | |
| MousePheno | embryonic lethality during organogenesis | SPINT1 LEMD3 PAK4 ZFPM1 FOXI3 FOXA2 BRAP SALL1 TAL1 TBX2 TBX4 EP400 DYNC2I2 FLVCR1 CHD7 SIRT1 LEFTY2 LEFTY1 KMT2D TRIM28 VRTN AKAP13 PRDM6 GAB1 CRB2 | 3.43e-04 | 876 | 190 | 25 | MP:0006207 |
| MousePheno | abnormal palate development | 3.77e-04 | 129 | 190 | 8 | MP:0009653 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | ZSWIM8 GAK SALL3 AQP11 FOXI3 FOXA2 WASHC2A AHDC1 ADCY3 FAH SALL1 ACAN MN1 FOXF2 NOVA2 TBX2 CACNA1C DYNC2I2 EBF3 BICRA FLVCR1 POU2F2 SIRT1 MSX1 MEGF8 MTF1 DCHS1 SMARCC2 ELN PAX9 CMTM7 GAB1 | 4.50e-04 | 1269 | 190 | 32 | MP:0011111 |
| MousePheno | abnormal artery development | 4.63e-04 | 133 | 190 | 8 | MP:0003410 | |
| MousePheno | abnormal pterygoid bone morphology | 4.97e-04 | 12 | 190 | 3 | MP:0004453 | |
| MousePheno | pterygoid bone hypoplasia | 5.46e-04 | 3 | 190 | 2 | MP:0004455 | |
| MousePheno | absent alveolar process | 5.46e-04 | 3 | 190 | 2 | MP:0000094 | |
| MousePheno | vomer bone hypoplasia | 5.46e-04 | 3 | 190 | 2 | MP:0009900 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 5.46e-04 | 3 | 190 | 2 | MP:0011311 | |
| MousePheno | abnormal digestive system morphology | CDX2 SALL3 KIF26A MBD6 FOXI3 FOXA2 MEX3A SALL1 HOXD12 ACAN MLLT6 MN1 FOXF2 FOXL1 TBX2 VAX1 WNT9B CHD7 SIRT1 LEFTY2 MSX1 LEFTY1 IGF2BP1 MEGF8 TRIM28 DCHS1 PAX9 PAN3 GAB1 CRB2 HR | 5.87e-04 | 1233 | 190 | 31 | MP:0000462 |
| Domain | Homeodomain-like | MTA2 CDX2 IRX5 HOXA6 HOXD12 VAX1 TCF3 EP400 DBX2 POU2F2 POU5F1 MSX1 VRTN ZFHX2 SMARCC2 ZFHX3 SSH2 PAX9 | 9.85e-08 | 332 | 222 | 18 | IPR009057 |
| Domain | ZnF_C2HC | FAM90A14 PNMA3 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 2.65e-07 | 55 | 222 | 8 | SM00343 |
| Domain | Znf_CCHC | FAM90A14 PNMA3 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 2.65e-07 | 55 | 222 | 8 | IPR001878 |
| Domain | - | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 VRTN ZFHX2 SMARCC2 ZFHX3 SSH2 | 7.81e-06 | 283 | 222 | 14 | 1.10.10.60 |
| Domain | Homeobox_CS | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.45e-05 | 186 | 222 | 11 | IPR017970 |
| Domain | Homeobox | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.17e-04 | 234 | 222 | 11 | PF00046 |
| Domain | HOMEOBOX_1 | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.26e-04 | 236 | 222 | 11 | PS00027 |
| Domain | HOX | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.31e-04 | 237 | 222 | 11 | SM00389 |
| Domain | LRDF | 1.41e-04 | 2 | 222 | 2 | IPR003942 | |
| Domain | HOMEOBOX_2 | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.41e-04 | 239 | 222 | 11 | PS50071 |
| Domain | Homeobox_dom | CDX2 IRX5 HOXA6 HOXD12 VAX1 DBX2 POU2F2 POU5F1 MSX1 ZFHX2 ZFHX3 | 1.41e-04 | 239 | 222 | 11 | IPR001356 |
| Domain | TF_fork_head_CS_2 | 2.09e-04 | 46 | 222 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.32e-04 | 47 | 222 | 5 | IPR018122 | |
| Domain | FH | 2.83e-04 | 49 | 222 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.83e-04 | 49 | 222 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.83e-04 | 49 | 222 | 5 | PS00658 | |
| Domain | Fork_head_dom | 2.83e-04 | 49 | 222 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.83e-04 | 49 | 222 | 5 | PS50039 | |
| Domain | Forkhead | 2.83e-04 | 49 | 222 | 5 | PF00250 | |
| Domain | Sec16_C | 4.19e-04 | 3 | 222 | 2 | PF12931 | |
| Domain | Vg_fam | 4.19e-04 | 3 | 222 | 2 | IPR011520 | |
| Domain | ACE1_Sec16_Sec31 | 4.19e-04 | 3 | 222 | 2 | IPR024298 | |
| Domain | Vg_Tdu | 4.19e-04 | 3 | 222 | 2 | PF07545 | |
| Domain | Galectin_CRD | 6.78e-04 | 15 | 222 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 6.78e-04 | 15 | 222 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 6.78e-04 | 15 | 222 | 3 | SM00908 | |
| Domain | GALECTIN | 6.78e-04 | 15 | 222 | 3 | PS51304 | |
| Domain | GLECT | 6.78e-04 | 15 | 222 | 3 | SM00276 | |
| Domain | TDU | 8.31e-04 | 4 | 222 | 2 | SM00711 | |
| Domain | COE | 8.31e-04 | 4 | 222 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 8.31e-04 | 4 | 222 | 2 | IPR003523 | |
| Domain | COE_HLH | 8.31e-04 | 4 | 222 | 2 | IPR032201 | |
| Domain | COE_DBD | 8.31e-04 | 4 | 222 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 8.31e-04 | 4 | 222 | 2 | IPR018350 | |
| Domain | COE1_HLH | 8.31e-04 | 4 | 222 | 2 | PF16423 | |
| Domain | COE1_DBD | 8.31e-04 | 4 | 222 | 2 | PF16422 | |
| Domain | TDU_repeat | 8.31e-04 | 4 | 222 | 2 | IPR006627 | |
| Domain | Cadherin_tail | 9.43e-04 | 37 | 222 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 9.43e-04 | 37 | 222 | 4 | IPR031904 | |
| Domain | - | 9.50e-04 | 95 | 222 | 6 | 2.60.120.200 | |
| Domain | KU | 1.18e-03 | 18 | 222 | 3 | SM00131 | |
| Domain | - | 1.18e-03 | 18 | 222 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.18e-03 | 18 | 222 | 3 | IPR020901 | |
| Domain | - | 1.23e-03 | 218 | 222 | 9 | 1.10.10.10 | |
| Domain | HTH_motif | 1.37e-03 | 69 | 222 | 5 | IPR000047 | |
| Domain | BPTI_KUNITZ_1 | 1.39e-03 | 19 | 222 | 3 | PS00280 | |
| Domain | BPTI_KUNITZ_2 | 1.39e-03 | 19 | 222 | 3 | PS50279 | |
| Domain | Kunitz_BPTI | 1.39e-03 | 19 | 222 | 3 | PF00014 | |
| Domain | LamG | 1.82e-03 | 44 | 222 | 4 | SM00282 | |
| Domain | HSF_fam | 2.04e-03 | 6 | 222 | 2 | IPR027725 | |
| Domain | TF_Brachyury | 2.04e-03 | 6 | 222 | 2 | IPR002070 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | MTA2 NR2F6 CDX2 SALL3 MEF2D SALL1 MBD2 EP400 ICAM1 POU5F1 LEFTY2 LEFTY1 FOXD3 KMT2D TRIM28 GAB1 | 2.93e-07 | 301 | 159 | 16 | MM15983 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 2.30e-05 | 31 | 159 | 5 | M27393 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NR2F6 CDX2 ZBTB38 IRX5 ESR1 ZFPM1 TSC22D2 SOX8 ZNF236 FOXI3 FOXA2 MEF2D HOXA6 SALL1 HOXD12 PLAGL1 UNKL HSF1 HSF4 TAL1 FOXF2 EBF4 FOXL1 TBX2 VAX1 TCF3 TBX4 DBX2 EBF3 POU2F2 POU5F1 HIF3A MSX1 FOXD3 KMT2D EGR1 MTF1 MZF1 ZFHX2 ZFHX3 PAX9 | 9.63e-22 | 908 | 239 | 41 | 19274049 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NUP58 MBD6 AHDC1 ZNF462 PRR12 TNRC18 SALL1 ZMIZ2 SEC16A TBX2 TCF20 EP400 SOBP BICRA FBRS PROSER1 CHD7 NUP214 SIRT1 KMT2D MDC1 SMARCC2 ZFHX3 PRDM6 YTHDF3 | 3.84e-18 | 351 | 239 | 25 | 38297188 |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 5.24e-18 | 25 | 239 | 11 | 17684299 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 NR2F6 KIF26A PPRC1 ZFPM1 ATG2A MBD6 ZNF236 WASHC2A AHDC1 KIAA2013 CABLES1 GGT7 CDR2L PRR12 TNRC18 ZMIZ2 SEC16A NLRC5 UNKL MLLT6 LRFN1 EP400 BICRA TMEM158 FBRS PAPLN NUP214 GRIN2D IDUA KMT2D AATK MEGF8 TRIM28 CSPG4 NINL AKAP13 UBE3C HR | 4.75e-17 | 1105 | 239 | 39 | 35748872 |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.21e-14 | 23 | 239 | 9 | 18602769 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRO ESR1 ATG2A TSC22D2 TNRC18 POM121 SALL1 ZMIZ2 MLLT6 SLA2 MAGED1 EP400 BICRA ASAP3 CHD7 NUP214 AATK EGR1 MDC1 AKAP13 TNKS GAB1 | 3.71e-13 | 430 | 239 | 22 | 35044719 |
| Pubmed | ILF2 ESR1 TNRC6B MBD6 WASHC2A MEF2D ZNF462 PRR12 SALL1 UBAP2L ZMIZ2 SEC16A MLLT6 MBD2 TAL1 FOXL1 TCF3 MAGED1 TCF20 EP400 LIMD1 SOBP BICRA FBRS PROSER1 CHD7 NUP214 RFC1 SIRT1 IGF2BP1 KMT2D PRCC MDC1 SMARCC2 ZFHX3 PAX9 PAN3 YTHDF3 | 8.96e-13 | 1429 | 239 | 38 | 35140242 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 SMPDL3A FAM90A19 C11orf54 FAM90A1 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 PRLR FAM90A10 | 1.34e-10 | 164 | 239 | 13 | 22967998 |
| Pubmed | MTA2 ESR1 MEF2D HOXA6 ZNF462 HOXD12 ZMIZ2 MAML3 FOXL1 TCF3 TBX4 TCF20 LIMD1 EBF3 POU2F2 TACC2 HIF3A FOXD3 MTF1 TRIM28 ZFHX2 ZFHX3 PAX9 NPAS4 | 1.75e-10 | 709 | 239 | 24 | 22988430 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MTA2 NR2F6 CDX2 ESR1 SOX8 ZNF236 HOXA6 HOXD12 TAL1 MAML3 VGLL1 EBF4 TBX2 TCF3 TBX4 TCF20 EBF3 RFC1 SIRT1 MSX1 EGR1 MTF1 MZF1 TRIM28 PAX9 HR | 5.01e-10 | 877 | 239 | 26 | 20211142 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | NR2F6 CDX2 IRX5 ESR1 SOX8 FOXA2 MEF2D HOXA6 HOXD12 HSF1 HSF4 TBX2 VAX1 POU2F2 POU5F1 MSX1 FOXD3 EGR1 MTF1 PAX9 | 1.54e-09 | 544 | 239 | 20 | 28473536 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | LEMD3 TNRC6B NUP58 FOXA2 AHDC1 MEF2D PRR12 POM121 SEC16A AGFG2 ALDH2 MAML3 TCF20 FBRS NUP214 KMT2D YTHDF3 | 2.28e-08 | 457 | 239 | 17 | 32344865 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | MTA2 ZSWIM8 ILF2 SALL3 ZFPM1 NUP58 ZNF462 SCML2 SALL1 HSD17B4 EP400 PROSER1 CHD7 TRIM28 VRTN SMARCC2 | 3.20e-08 | 411 | 239 | 16 | 35182466 |
| Pubmed | MTA2 GLCCI1 POM121 UBAP2L SEC16A MAGED1 NUP214 IGF2BP1 DCHS1 | 3.54e-08 | 101 | 239 | 9 | 26949739 | |
| Pubmed | MTA2 ILF2 PAK4 TNRC6B WASHC2A MEF2D SCML2 SEC16A HSD17B4 TCF20 EP400 LIMD1 RANBP9 SEC31A NECAP2 PRCC YTHDF3 | 3.64e-08 | 472 | 239 | 17 | 38943005 | |
| Pubmed | GAK LEMD3 TNRC6B CWC25 WASHC2A BRAP GGT7 SCML2 MEX3A SEC16A MAGED1 TCF20 EP400 CHD7 NUP214 NPTN NECAP2 MDC1 AKAP13 UBE3C YTHDF3 | 4.53e-08 | 733 | 239 | 21 | 34672954 | |
| Pubmed | AHDC1 MEF2D PRR12 TNRC18 SCML2 MBD2 TCF20 EP400 FBRS CHD7 KMT2D MDC1 SMARCC2 | 5.15e-08 | 268 | 239 | 13 | 33640491 | |
| Pubmed | MTA2 CDX2 SALL3 ESR1 ZNF236 MEF2D ZNF462 SALL1 ZMIZ2 MLLT6 HSF1 TBX4 TCF20 LIMD1 EBF3 POU2F2 POU5F1 MSX1 EGR1 MTF1 TRIM28 ZFHX3 | 5.21e-08 | 808 | 239 | 22 | 20412781 | |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 7.81e-08 | 53 | 239 | 7 | 21532573 | |
| Pubmed | 1.31e-07 | 57 | 239 | 7 | 34671097 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2F6 CDX2 SETX TRO SENP3 FOXA2 MEF2D SALL1 MBD2 NOTCH3 FOXF2 NOVA2 FOXL1 TBX2 EP400 EBF3 POU2F2 FOXD3 KMT2D ABI2 SMARCC2 PRDM6 | 1.44e-07 | 857 | 239 | 22 | 25609649 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ILF2 SETX SALL3 LEMD3 CWC25 MEF2D SCML2 SALL1 UBAP2L SEC16A MLLT6 TCF20 EP400 BICRA CHD7 NUP214 RFC1 IGF2BP1 PRCC TRIM28 MDC1 SMARCC2 YTHDF3 | 2.24e-07 | 954 | 239 | 23 | 36373674 |
| Pubmed | ILF2 SENP3 ANKS1B TNRC6B ZNF462 AP1B1 UBAP2L SEC16A LRFN1 MAGED1 TCF20 EBF3 RANBP9 CHD7 SEC31A GRIN2D NPTN ABI2 TRIM28 DCHS1 SMARCC2 TNKS SSH2 | 2.64e-07 | 963 | 239 | 23 | 28671696 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | MTA2 SALL3 ZNF462 SALL1 MBD2 EP400 POU5F1 KMT2D VRTN SMARCC2 | 2.68e-07 | 167 | 239 | 10 | 20362541 |
| Pubmed | Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. | 2.73e-07 | 21 | 239 | 5 | 18781635 | |
| Pubmed | SETX KIF26A PAK4 NUP58 MEF2D POM121 TCF20 BICRA RANBP9 NUP214 SEC31A EGR1 TRIM28 AKAP13 DUSP10 GAB1 | 3.10e-07 | 486 | 239 | 16 | 20936779 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 33316546 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 28704475 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.20e-07 | 3 | 239 | 3 | 7890611 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 32380082 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 23667648 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 28877989 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 19800850 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 37105392 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 36479526 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.20e-07 | 3 | 239 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.20e-07 | 3 | 239 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.20e-07 | 3 | 239 | 3 | 31969388 | |
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.20e-07 | 3 | 239 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.20e-07 | 3 | 239 | 3 | 29458010 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 26582205 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 9153289 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 23144904 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 21146220 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 16990264 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18005988 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 23585851 | ||
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.20e-07 | 3 | 239 | 3 | 25898318 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18282810 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.20e-07 | 3 | 239 | 3 | 25931247 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 17560833 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 19776007 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 9038233 | ||
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.20e-07 | 3 | 239 | 3 | 22341088 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 38987795 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.20e-07 | 3 | 239 | 3 | 35241678 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 22627368 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 33153471 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 22052881 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 35643073 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18974023 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.20e-07 | 3 | 239 | 3 | 29651447 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.20e-07 | 3 | 239 | 3 | 28990062 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18579572 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.20e-07 | 3 | 239 | 3 | 29433546 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 31937306 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 21426359 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 24083426 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 37279535 | ||
| Pubmed | Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. | 3.52e-07 | 22 | 239 | 5 | 16678814 | |
| Pubmed | 3.52e-07 | 22 | 239 | 5 | 21896659 | ||
| Pubmed | SPC4/PACE4 regulates a TGFbeta signaling network during axis formation. | 4.42e-07 | 10 | 239 | 4 | 10809672 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MTA2 SETX TNRC6B AHDC1 MEF2D SALL1 UBAP2L SEC16A HSF1 MAGED1 EP400 TACC2 PRCC TRIM28 YTHDF3 | 5.30e-07 | 444 | 239 | 15 | 34795231 |
| Pubmed | Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. | 5.61e-07 | 24 | 239 | 5 | 20573697 | |
| Pubmed | SALL3 ESR1 SALL1 NRXN2 NOTCH3 FOXF2 TBX4 WNT9B CHD7 LEFTY2 MSX1 LIPC PAX9 | 5.80e-07 | 331 | 239 | 13 | 20634891 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 6.91e-07 | 11 | 239 | 4 | 9655502 | |
| Pubmed | 7.34e-07 | 73 | 239 | 7 | 22094256 | ||
| Pubmed | MTA2 ILF2 SALL3 LEMD3 SCML2 SALL1 MAGED1 TCF20 EP400 CHD7 POU5F1 MDC1 VRTN SMARCC2 | 7.47e-07 | 396 | 239 | 14 | 26687479 | |
| Pubmed | MTA2 ILF2 SETX AHDC1 MEF2D PRR12 TNRC18 AP1B1 ZMIZ2 MLLT6 HSD17B4 MBD2 TCF3 TCF20 EP400 EBF3 BICRA CHD7 RFC1 SIRT1 IGF2BP1 KMT2D EGR1 SMARCC2 | 7.56e-07 | 1103 | 239 | 24 | 34189442 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | PRR12 TNRC18 SALL1 ZMIZ2 SEC16A TCF20 EP400 BICRA FBRS CHD7 FAM90A1 KMT2D SMARCC2 TNKS | 7.93e-07 | 398 | 239 | 14 | 35016035 |
| Pubmed | 9.21e-07 | 191 | 239 | 10 | 24146773 | ||
| Pubmed | Identification of 15 loci influencing height in a Korean population. | 1.05e-06 | 27 | 239 | 5 | 19893584 | |
| Pubmed | Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency. | 1.05e-06 | 27 | 239 | 5 | 27586544 | |
| Pubmed | 1.18e-06 | 152 | 239 | 9 | 38360978 | ||
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 1.18e-06 | 152 | 239 | 9 | 28192407 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 22677125 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 19234217 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 35715604 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.28e-06 | 4 | 239 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.28e-06 | 4 | 239 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.28e-06 | 4 | 239 | 3 | 33727589 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 18826117 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.28e-06 | 4 | 239 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.28e-06 | 4 | 239 | 3 | 18346632 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 19670381 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 25450716 | ||
| Interaction | TOP3B interactions | MTA2 NR2F6 KIF26A PPRC1 TNRC6B ZFPM1 ATG2A MBD6 ZNF236 WASHC2A AHDC1 KIAA2013 CABLES1 GGT7 CDR2L PRR12 TNRC18 UBAP2L ZMIZ2 SEC16A NLRC5 UNKL MLLT6 FOXL1 LRFN1 EP400 BICRA TMEM158 FBRS PAPLN NUP214 GRIN2D IDUA IGF2BP1 KMT2D AATK MEGF8 TRIM28 CSPG4 MDC1 NINL AKAP13 UBE3C YTHDF3 HR | 2.12e-10 | 1470 | 220 | 45 | int:TOP3B |
| Interaction | TLE3 interactions | ESR1 AHDC1 PRR12 TNRC18 POM121 SALL1 ZMIZ2 AGFG2 MLLT6 FOXL1 TCF3 MAGED1 TCF20 EBF3 FBRS PROSER1 KMT2D EGR1 SMARCC2 ZFHX3 PAX9 | 1.08e-09 | 376 | 220 | 21 | int:TLE3 |
| Interaction | EGR2 interactions | SOX8 AHDC1 ZNF462 PRR12 TNRC18 ZMIZ2 SEC16A EP400 BICRA FBRS PROSER1 CHD7 KMT2D ZFHX3 | 6.05e-09 | 171 | 220 | 14 | int:EGR2 |
| Interaction | NUP35 interactions | LEMD3 ESR1 TNRC6B NUP58 FOXA2 AHDC1 MEF2D PRR12 POM121 SEC16A AGFG2 ALDH2 MAML3 SLC27A5 TCF20 FBRS NUP214 KMT2D TRIM28 YTHDF3 | 4.65e-08 | 424 | 220 | 20 | int:NUP35 |
| Interaction | POU5F1 interactions | MTA2 CDX2 ILF2 SALL3 LEMD3 ESR1 PAK4 SOX8 ZNF462 SCML2 SALL1 UBAP2L TCF20 EP400 CHD7 POU5F1 RFC1 COL18A1 FOXD3 TRIM28 MDC1 SMARCC2 ZFHX3 | 1.19e-07 | 584 | 220 | 23 | int:POU5F1 |
| Interaction | CRX interactions | ZNF462 PRR12 TNRC18 SALL1 ZMIZ2 MLLT6 TCF20 EP400 BICRA FBRS PROSER1 CHD7 KMT2D ABI2 ZFHX3 | 1.38e-07 | 254 | 220 | 15 | int:CRX |
| Interaction | PAX9 interactions | MEF2D PRR12 ZMIZ2 TCF20 FBRS PROSER1 CHD7 MSX1 KMT2D ZFHX3 PAX9 | 1.91e-07 | 130 | 220 | 11 | int:PAX9 |
| Interaction | SOX7 interactions | 2.75e-07 | 82 | 220 | 9 | int:SOX7 | |
| Interaction | GSC interactions | 4.59e-07 | 87 | 220 | 9 | int:GSC | |
| Interaction | CREBBP interactions | GAK CDX2 ESR1 ANKS1B MEX3A AP1B1 HOXD12 PLAGL1 HSF1 MBD2 TAL1 TCF3 ICAM1 TACC2 MSX1 KMT2D EGR1 MTF1 TRIM28 MDC1 SMARCC2 PRLR | 7.37e-07 | 599 | 220 | 22 | int:CREBBP |
| Interaction | SOX17 interactions | 9.74e-07 | 95 | 220 | 9 | int:SOX17 | |
| Interaction | SOX6 interactions | ILF2 MEF2D ZMIZ2 MBD2 TCF20 SOBP FBRS PROSER1 CHD7 IGF2BP1 ZFHX3 | 1.27e-06 | 157 | 220 | 11 | int:SOX6 |
| Interaction | SOX2 interactions | MTA2 ILF2 SALL3 SENP3 SOX8 CWC25 WASHC2A AHDC1 MEF2D ZNF462 PRR12 TNRC18 SALL1 ZMIZ2 SEC16A ALDH2 MBD2 TBX2 PTBP3 COL6A3 TCF3 MAGED1 TCF20 EP400 FBRS RANBP9 PROSER1 CHD7 POU5F1 NUP214 RFC1 IGF2BP1 KMT2D TRIM28 SMARCC2 ZFHX3 | 1.88e-06 | 1422 | 220 | 36 | int:SOX2 |
| Interaction | USP7 interactions | ZBTB38 SALL3 TRO ESR1 TSC22D2 KIAA2013 CDR2L NUTM1 PRR12 SCML2 SALL1 ZMIZ2 HSF1 TAL1 PNMA3 FOXL1 CACNA1C TCF3 MAGED1 TCF20 FIGNL2 RANBP9 POU5F1 RFC1 SIRT1 LGALS9 FOXD3 IGF2BP1 KMT2D MDC1 NINL MMRN2 ZFHX2 SMARCC2 | 2.31e-06 | 1313 | 220 | 34 | int:USP7 |
| Interaction | GATA4 interactions | MTA2 ZSWIM8 ILF2 SALL3 ZFPM1 ZNF462 SALL1 HSD17B4 EP400 PROSER1 CHD7 SEC31A TRIM28 MDC1 VRTN SMARCC2 PAX9 | 2.97e-06 | 411 | 220 | 17 | int:GATA4 |
| Interaction | SMARCA4 interactions | MTA2 CDX2 ESR1 SCML2 MEX3A ZMIZ2 HSF1 HSF4 MBD2 TCF3 EP400 BICRA CHD7 POU5F1 EGR1 TRIM28 MDC1 SMARCC2 | 3.48e-06 | 462 | 220 | 18 | int:SMARCA4 |
| Interaction | ASF1A interactions | MTA2 ESR1 MEF2D MLLT6 TCF20 EP400 BICRA CHD7 POU5F1 KMT2D MDC1 SMARCC2 PAN3 | 3.77e-06 | 249 | 220 | 13 | int:ASF1A |
| Interaction | AR interactions | GAK ILF2 ESR1 AHDC1 MEF2D RPRD1B ZNF462 PRR12 TNRC18 SCML2 UBAP2L ZMIZ2 SEC16A MBD2 MAGED1 TCF20 EP400 FBRS RANBP9 POU2F2 CHD7 POU5F1 SIRT1 KMT2D TRIM28 MDC1 SMARCC2 ZFHX3 | 4.05e-06 | 992 | 220 | 28 | int:AR |
| Interaction | NKX2-1 interactions | MTA2 NR2F6 ILF2 NUP58 FOXA2 TCF20 CHD7 RFC1 TRIM28 MDC1 ZFHX3 | 4.80e-06 | 180 | 220 | 11 | int:NKX2-1 |
| Interaction | PPIA interactions | MTA2 ILF2 SALL3 ESR1 PAK4 TNRC6B MBD6 WASHC2A MEF2D SCML2 SEC16A HSD17B4 MBD2 NOTCH3 TCF20 EP400 LIMD1 RANBP9 POU5F1 SEC31A RFC1 LGALS9 NECAP2 PRCC PRLR YTHDF3 | 4.81e-06 | 888 | 220 | 26 | int:PPIA |
| Interaction | HELZ interactions | ESR1 TNRC6B POM121 UBAP2L SEC16A HSF1 MAGED1 EBF3 FBRS POU5F1 IGF2BP1 PAN3 YTHDF3 | 5.32e-06 | 257 | 220 | 13 | int:HELZ |
| Interaction | NANOG interactions | MTA2 ILF2 SALL3 LEMD3 SENP3 AHDC1 ZNF462 SALL1 SEC16A MBD2 MAGED1 TCF20 EP400 CHD7 POU5F1 IGF2BP1 TRIM28 VRTN | 6.08e-06 | 481 | 220 | 18 | int:NANOG |
| Interaction | SP7 interactions | NR2F6 MEF2D PRR12 ZMIZ2 TCF20 EP400 BICRA FBRS PROSER1 CHD7 IGF2BP1 KMT2D PRCC SMARCC2 | 6.79e-06 | 304 | 220 | 14 | int:SP7 |
| Interaction | KLF5 interactions | MTA2 CDX2 ILF2 ESR1 MEF2D PRR12 SEC16A EP400 POU5F1 KMT2D YTHDF3 | 1.03e-05 | 195 | 220 | 11 | int:KLF5 |
| Interaction | SOX5 interactions | ILF2 MBD2 MAGED1 TCF20 PROSER1 CHD7 POU5F1 IGF2BP1 KMT2D ZFHX3 | 1.19e-05 | 162 | 220 | 10 | int:SOX5 |
| Interaction | R3HDM2 interactions | ZSWIM8 TNRC6B MEX3A UBAP2L SEC16A MAGED1 IGF2BP1 PAN3 YTHDF3 | 1.23e-05 | 129 | 220 | 9 | int:R3HDM2 |
| Interaction | TFCP2L1 interactions | 1.30e-05 | 99 | 220 | 8 | int:TFCP2L1 | |
| Interaction | KDM1A interactions | MTA2 ESR1 TNRC6B ZFPM1 SOX8 MEF2D ZNF462 PRR12 SEC16A UNKL HSF1 MBD2 TAL1 TCF3 TCF20 EP400 FBRS RANBP9 CHD7 POU5F1 NUP214 KMT2D TRIM28 SMARCC2 ZFHX3 UBE3C | 1.34e-05 | 941 | 220 | 26 | int:KDM1A |
| Interaction | TOP2A interactions | MTA2 ZBTB38 ILF2 ESR1 MBD6 MEX3A FH HSF1 MN1 DUOX2 POU5F1 RFC1 LGALS9 FOXD3 IGF2BP1 TRIM28 NINL YTHDF3 | 1.74e-05 | 520 | 220 | 18 | int:TOP2A |
| Interaction | TLX1 interactions | MEF2D ZNF462 PRR12 SALL1 TCF20 FBRS CHD7 IGF2BP1 KMT2D ZFHX3 | 2.34e-05 | 175 | 220 | 10 | int:TLX1 |
| Interaction | TRPS1 interactions | 2.81e-05 | 143 | 220 | 9 | int:TRPS1 | |
| Interaction | HDAC1 interactions | MTA2 ESR1 TNRC6B ZFPM1 SOX8 MEF2D XYLT2 TNRC18 SALL1 ZMIZ2 PLAGL1 HSF1 MBD2 TAL1 TCF20 EP400 FBRS RANBP9 POU5F1 NUP214 RFC1 SIRT1 KMT2D TRIM28 SMARCC2 ZFHX3 PRDM6 HR | 3.08e-05 | 1108 | 220 | 28 | int:HDAC1 |
| Interaction | ZFP36 interactions | TNRC6B MEX3A AP1B1 UBAP2L SEC16A MAGED1 NUP214 IGF2BP1 PAN3 YTHDF3 | 3.12e-05 | 181 | 220 | 10 | int:ZFP36 |
| Interaction | SALL3 interactions | 3.18e-05 | 34 | 220 | 5 | int:SALL3 | |
| Interaction | ZMYND12 interactions | 3.19e-05 | 82 | 220 | 7 | int:ZMYND12 | |
| Interaction | SMARCD2 interactions | 3.43e-05 | 183 | 220 | 10 | int:SMARCD2 | |
| Interaction | IRF4 interactions | 4.03e-05 | 85 | 220 | 7 | int:IRF4 | |
| Interaction | RBBP7 interactions | MTA2 ZBTB38 ESR1 ZFPM1 ZNF462 TNRC18 SALL1 MBD2 TAL1 TCF3 TCF20 EP400 POU5F1 SIRT1 TRIM28 NINL SMARCC2 | 4.46e-05 | 507 | 220 | 17 | int:RBBP7 |
| Interaction | HNF1B interactions | 4.71e-05 | 190 | 220 | 10 | int:HNF1B | |
| Interaction | FAM120C interactions | ESR1 TNRC6B MEX3A UBAP2L SEC16A PTBP3 MAGED1 IGF2BP1 PAN3 YTHDF3 | 4.93e-05 | 191 | 220 | 10 | int:FAM120C |
| Interaction | CNOT9 interactions | ESR1 TNRC6B SALL1 UBAP2L SEC16A MAGED1 AATK UHMK1 NINL PAN3 YTHDF3 | 4.93e-05 | 231 | 220 | 11 | int:CNOT9 |
| Interaction | SMG7 interactions | ZSWIM8 TNRC6B MEF2D PRR12 SALL1 UBAP2L SEC16A MLLT6 TCF20 SIRT1 KMT2D NINL YTHDF3 | 5.19e-05 | 319 | 220 | 13 | int:SMG7 |
| Interaction | EP300 interactions | MTA2 CDX2 ILF2 ESR1 SENP3 MEF2D RPRD1B NUTM1 MEX3A AP1B1 PLAGL1 HSF1 TAL1 MN1 TBX2 TCF3 MAGED1 TENT4A TACC2 SEC31A SIRT1 IGF2BP1 KMT2D EGR1 MTF1 PRCC TRIM28 MDC1 SMARCC2 UBE3C PAX9 PRDM6 | 5.74e-05 | 1401 | 220 | 32 | int:EP300 |
| Interaction | SAMD4B interactions | 5.89e-05 | 122 | 220 | 8 | int:SAMD4B | |
| Interaction | MTA1 interactions | MTA2 ESR1 ZFPM1 SALL1 HSF1 MBD2 CHD7 POU5F1 SIRT1 SMARCC2 AKAP13 UBE3C | 6.92e-05 | 283 | 220 | 12 | int:MTA1 |
| Interaction | VRTN interactions | 7.15e-05 | 21 | 220 | 4 | int:VRTN | |
| Interaction | SMARCE1 interactions | MTA2 ESR1 BRAP ZMIZ2 MBD2 TCF3 BICRA CHD7 POU5F1 TRIM28 MDC1 SMARCC2 | 7.90e-05 | 287 | 220 | 12 | int:SMARCE1 |
| Interaction | FEV interactions | 8.21e-05 | 203 | 220 | 10 | int:FEV | |
| Interaction | MARF1 interactions | 8.26e-05 | 128 | 220 | 8 | int:MARF1 | |
| Interaction | ZKSCAN1 interactions | 8.32e-05 | 66 | 220 | 6 | int:ZKSCAN1 | |
| Interaction | PCDHA10 interactions | 8.66e-05 | 22 | 220 | 4 | int:PCDHA10 | |
| Interaction | RBMS1 interactions | ESR1 TNRC6B MEX3A UBAP2L PTBP3 MAGED1 RANBP9 IGF2BP1 PAN3 YTHDF3 | 9.65e-05 | 207 | 220 | 10 | int:RBMS1 |
| Interaction | RCOR1 interactions | MTA2 TNRC6B SOX8 SALL1 SEC16A MBD2 TAL1 TCF3 FBRS RANBP9 CHD7 KMT2D TRIM28 NINL SMARCC2 ZFHX3 | 1.12e-04 | 494 | 220 | 16 | int:RCOR1 |
| Interaction | KDM5B interactions | 1.14e-04 | 100 | 220 | 7 | int:KDM5B | |
| Interaction | FAM90A26 interactions | 1.19e-04 | 2 | 220 | 2 | int:FAM90A26 | |
| Interaction | SALL1 interactions | 1.29e-04 | 102 | 220 | 7 | int:SALL1 | |
| Interaction | TNRC6C interactions | 1.40e-04 | 138 | 220 | 8 | int:TNRC6C | |
| Interaction | TEAD1 interactions | 1.40e-04 | 176 | 220 | 9 | int:TEAD1 | |
| Interaction | H2BC3 interactions | MTA2 RPRD1B SCML2 FH TCF20 EP400 ICAM1 DUOX2 CHD7 RFC1 IGF2BP1 KMT2D MDC1 SMARCC2 | 1.59e-04 | 406 | 220 | 14 | int:H2BC3 |
| Interaction | LMO2 interactions | ATG2A RPRD1B NUTM1 TAL1 MN1 TBX2 TCF3 LIMD1 FAM90A1 ABI2 PAX9 PRDM6 | 1.63e-04 | 310 | 220 | 12 | int:LMO2 |
| Interaction | TLX2 interactions | 1.70e-04 | 142 | 220 | 8 | int:TLX2 | |
| Interaction | NR3C1 interactions | MTA2 NR2F6 SENP3 RPRD1B SALL1 AP1B1 HSD17B4 MBD2 MAML3 FOXL1 TBX4 TCF20 ICAM1 FBRS RANBP9 POU2F2 CHD7 NUP214 RFC1 KMT2D MEGF8 EGR1 TRIM28 SMARCC2 | 1.72e-04 | 974 | 220 | 24 | int:NR3C1 |
| Interaction | MPDZ interactions | 1.74e-04 | 107 | 220 | 7 | int:MPDZ | |
| Interaction | ALG13 interactions | 1.88e-04 | 183 | 220 | 9 | int:ALG13 | |
| Interaction | SMARCB1 interactions | MTA2 CDX2 SCML2 HSF1 MBD2 BICRA TACC2 POU5F1 FAM90A1 ABI2 TRIM28 MDC1 SMARCC2 | 1.94e-04 | 364 | 220 | 13 | int:SMARCB1 |
| Interaction | DAZL interactions | 1.97e-04 | 145 | 220 | 8 | int:DAZL | |
| Interaction | SLC25A37 interactions | 1.98e-04 | 11 | 220 | 3 | int:SLC25A37 | |
| Interaction | ITSN2 interactions | 2.16e-04 | 147 | 220 | 8 | int:ITSN2 | |
| Interaction | XRCC6 interactions | MTA2 CDX2 ZBTB38 ILF2 ESR1 MBD6 TNRC18 SCML2 HSD17B4 HSF1 TAL1 TCF20 EP400 ICAM1 POU2F2 CHD7 POU5F1 RFC1 IGF2BP1 TRIM28 MDC1 ZFHX3 TNKS | 2.18e-04 | 928 | 220 | 23 | int:XRCC6 |
| Interaction | ARID1A interactions | MTA2 ESR1 MEX3A ALDH2 MBD2 BICRA CHD7 POU5F1 MDC1 SMARCC2 PAX9 | 2.37e-04 | 276 | 220 | 11 | int:ARID1A |
| Interaction | CHD7 interactions | 2.48e-04 | 150 | 220 | 8 | int:CHD7 | |
| Interaction | DLX5 interactions | 2.65e-04 | 29 | 220 | 4 | int:DLX5 | |
| Interaction | DCAF4 interactions | NR2F6 SPINT1 TRO TNRC6B ATG2A MEX3A SEC16A PTBP3 MAGED1 PARP14 SIRT1 IGF2BP1 YTHDF3 | 2.79e-04 | 378 | 220 | 13 | int:DCAF4 |
| Interaction | FMR1 interactions | ILF2 ESR1 TNRC6B CWC25 MEX3A UBAP2L MAGED1 TCF20 RANBP9 TACC2 CHD7 IGF2BP1 AATK TRIM28 SMARCC2 YTHDF3 | 2.82e-04 | 536 | 220 | 16 | int:FMR1 |
| Interaction | SALL4 interactions | 2.96e-04 | 83 | 220 | 6 | int:SALL4 | |
| Interaction | MTA2 interactions | MTA2 ESR1 ZFPM1 XYLT2 SALL1 HSF1 MBD2 TCF20 CHD7 POU5F1 SIRT1 TRIM28 SMARCC2 UBE3C | 3.21e-04 | 435 | 220 | 14 | int:MTA2 |
| Interaction | CPEB4 interactions | 3.23e-04 | 156 | 220 | 8 | int:CPEB4 | |
| Interaction | MRE11 interactions | GAK CDX2 ILF2 ESR1 SENP3 POU5F1 RFC1 TRIM28 MDC1 SMARCC2 DUSP10 | 3.31e-04 | 287 | 220 | 11 | int:MRE11 |
| Interaction | PUM1 interactions | ILF2 TNRC6B PRR12 MEX3A UBAP2L SEC16A HSF1 PTBP3 MAGED1 IGF2BP1 YTHDF3 | 3.31e-04 | 287 | 220 | 11 | int:PUM1 |
| Interaction | GATA2 interactions | 3.51e-04 | 199 | 220 | 9 | int:GATA2 | |
| Interaction | EYA4 interactions | 3.53e-04 | 243 | 220 | 10 | int:EYA4 | |
| Interaction | TFE3 interactions | MTA2 SALL3 ZNF462 SALL1 TCF20 CHD7 POU5F1 IGF2BP1 TRIM28 VRTN ZFHX2 ZFHX3 | 4.20e-04 | 344 | 220 | 12 | int:TFE3 |
| Interaction | PCDHA7 interactions | 4.27e-04 | 14 | 220 | 3 | int:PCDHA7 | |
| Interaction | CFC1 interactions | 4.73e-04 | 126 | 220 | 7 | int:CFC1 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A23 TNKS FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.60e-10 | 154 | 240 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A23 TNKS FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 5.18e-08 | 234 | 240 | 11 | chr8p23 |
| Cytoband | 1q42.1 | 3.00e-05 | 12 | 240 | 3 | 1q42.1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.71e-06 | 25 | 150 | 5 | 775 | |
| GeneFamily | Galectins | 2.37e-04 | 15 | 150 | 3 | 629 | |
| GeneFamily | Vestigial like family | 4.06e-04 | 4 | 150 | 2 | 367 | |
| GeneFamily | Forkhead boxes | 4.37e-04 | 43 | 150 | 4 | 508 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.72e-04 | 53 | 150 | 4 | 532 | |
| GeneFamily | Clustered protocadherins | 1.97e-03 | 64 | 150 | 4 | 20 | |
| GeneFamily | Nucleoporins | 2.33e-03 | 32 | 150 | 3 | 1051 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.58e-03 | 11 | 150 | 2 | 1025 | |
| GeneFamily | Ankyrin repeat domain containing | 4.12e-03 | 242 | 150 | 7 | 403 | |
| GeneFamily | PHD finger proteins|NuRD complex | 4.27e-03 | 12 | 150 | 2 | 1305 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | CDX2 IRX5 VGLL2 ESR1 ZFPM1 SOX8 FOXA2 CSMD3 HOXA6 HOXD12 ACAN HSF4 TAL1 FOXF2 NOVA2 FOXL1 TBX2 VAX1 EBF3 DUOX2 GRIN2D MSX1 FOXD3 TRIM28 PRDM13 ZFHX3 PAX9 NPAS4 HR | 1.82e-07 | 1115 | 230 | 29 | M10371 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | LGALS9C TTC39B SPINT1 LGALS9B TNFRSF10A GLCCI1 KIAA2013 CDR2L FAH POM121 ZMIZ2 ALDH2 HSD17B4 TBX2 LRFN1 TMEM158 FLVCR1 DOLK FBRS HGSNAT NUDT22 IDUA SIRT1 LGALS9 COL18A1 PLEKHG6 EGR1 UHMK1 POM121B HR | 4.01e-07 | 1226 | 230 | 30 | MM979 |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | FOXL1 TBX4 PCDHA13 PCDHA12 PCDHA11 DUOX2 PCDHA10 PRDM13 NPAS4 | 4.14e-07 | 106 | 230 | 9 | MM1265 |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 3.62e-06 | 103 | 230 | 8 | M1967 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | GAK ATG2A MBD6 CWC25 MEF2D SMPDL3A ZMIZ2 NLRC5 GTPBP3 MBD2 PNMA3 BICRA IDUA MZF1 MDC1 SMARCC2 AKAP13 ZFHX3 CMTM7 | 3.70e-06 | 634 | 230 | 19 | M40866 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | LGALS9C LGALS9B GLCCI1 CDR2L FAH POM121 ZMIZ2 ALDH2 HSD17B4 TBX2 TMEM158 DOLK HGSNAT NUDT22 IDUA LGALS9 COL18A1 PLEKHG6 POM121B | 4.95e-06 | 647 | 230 | 19 | MM981 |
| Coexpression | PEREZ_TP53_TARGETS | GAK IRX5 CEL KIF26A WIPF3 RIPOR3 AHDC1 GLCCI1 UNKL MN1 FOXF2 DYNC2I2 LIMD1 ISOC1 DUOX2 IDUA VWCE LGALS9 MSX1 COL18A1 BICDL1 AIFM2 EGR1 CSPG4 PRDM6 GAB1 HR | 7.66e-06 | 1201 | 230 | 27 | M4391 |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 1.31e-05 | 6 | 230 | 3 | M1764 | |
| Coexpression | TESAR_ALK_TARGETS_HUMAN_ES_5D_DN | 2.27e-05 | 7 | 230 | 3 | M2811 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | CDX2 FOXA2 KCNA7 NRXN2 ACAN TAL1 FOXL1 VAX1 TCF20 WNT9B LEFTY2 LEFTY1 FOXD3 BICDL1 AATK PLEKHG6 PRLR | 2.54e-05 | 601 | 230 | 17 | MM866 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | TTC39B SPINT1 GLCCI1 KIAA2013 CDR2L FAH POM121 ZMIZ2 ALDH2 HSD17B4 TBX2 LRFN1 TMEM158 FLVCR1 DOLK HGSNAT NUDT22 IDUA SIRT1 LGALS9 COL18A1 PLEKHG6 EGR1 UHMK1 HR | 3.01e-05 | 1151 | 230 | 25 | M1103 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | CDX2 SPINT1 FOXA2 HOXD12 NOTCH3 FOXL1 FOXD3 IGF2BP1 PLEKHG6 PRDM13 PRDM6 | 3.11e-05 | 272 | 230 | 11 | M1938 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 4.12e-05 | 72 | 230 | 6 | M40882 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | CDX2 SPINT1 FOXA2 HOXD12 NOTCH3 FOXL1 FOXD3 IGF2BP1 PLEKHG6 PRDM13 PRDM6 | 4.31e-05 | 282 | 230 | 11 | MM822 |
| Coexpression | DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS | 4.57e-05 | 45 | 230 | 5 | M40098 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | GAK ATG2A MBD6 CWC25 MEF2D SMPDL3A ZMIZ2 NLRC5 PLAGL1 ALDH2 GTPBP3 MBD2 PNMA3 BICRA IDUA MZF1 MDC1 SMARCC2 AKAP13 ZFHX3 CMTM7 | 5.31e-05 | 905 | 230 | 21 | M40865 |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 7.00e-05 | 199 | 230 | 9 | M312 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 7.08e-05 | 155 | 230 | 8 | M39246 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 7.08e-05 | 155 | 230 | 8 | M8944 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | CDX2 FOXA2 KCNA7 NRXN2 ACAN TAL1 FOXL1 VAX1 TCF20 WNT9B LEFTY2 FOXD3 BICDL1 AATK PLEKHG6 PRLR | 7.38e-05 | 591 | 230 | 16 | M2019 |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 7.65e-05 | 10 | 230 | 3 | MM741 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | GLCCI1 CDR2L FAH POM121 ZMIZ2 ALDH2 HSD17B4 TBX2 TMEM158 DOLK HGSNAT NUDT22 IDUA LGALS9 COL18A1 PLEKHG6 | 1.09e-04 | 611 | 230 | 16 | M1106 |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP | 1.27e-04 | 126 | 230 | 7 | M8791 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | SALL3 SENP3 SOX8 CSMD3 TNRC18 SALL1 DBX2 EGR1 PRDM13 ELN IFI6 GAB1 CRB2 | 1.47e-04 | 439 | 230 | 13 | M39054 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.70e-04 | 59 | 230 | 5 | M47989 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 1.71e-04 | 32 | 230 | 4 | M308 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 9.98e-06 | 72 | 221 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 1.70e-05 | 78 | 221 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_1 | 1.88e-05 | 16 | 221 | 4 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.33e-05 | 118 | 221 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_100 | 7.96e-05 | 99 | 221 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 8.48e-05 | 100 | 221 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | PLAGL1 ALDH2 FOXF2 TBX2 COL6A3 TBX4 MAGED1 ISOC1 EGR1 ELN PRDM6 | 6.92e-09 | 196 | 231 | 11 | 028a06ed92f1c058dcbeacd335625bf529e87a7b |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.14e-08 | 182 | 231 | 10 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADCY3 NOTCH3 FOXF2 TBX2 CACNA1C COL6A3 TBX4 PAPLN COL18A1 CSPG4 | 4.59e-08 | 184 | 231 | 10 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-08 | 184 | 231 | 10 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.53e-08 | 191 | 231 | 10 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IRX5 WIPF3 SALL1 CASKIN2 PLAGL1 TAL1 TMEM158 COL18A1 MMRN2 ELN | 7.20e-08 | 193 | 231 | 10 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | ADCY3 ACAN NOTCH3 TBX2 CACNA1C TBX4 COL18A1 CSPG4 ZFHX3 PRDM6 | 8.32e-08 | 196 | 231 | 10 | 754a3613340932563cd8424d775e18b93c3a1aaa |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.32e-08 | 196 | 231 | 10 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Smooth_Muscle_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.59e-08 | 199 | 231 | 10 | 31c781a1787e5140fb3f611823cbab4d13d02dfa | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-07 | 179 | 231 | 9 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 5.08e-07 | 183 | 231 | 9 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.08e-07 | 183 | 231 | 9 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.32e-07 | 184 | 231 | 9 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.32e-07 | 184 | 231 | 9 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 189 | 231 | 9 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 189 | 231 | 9 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.96e-07 | 190 | 231 | 9 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.96e-07 | 190 | 231 | 9 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 191 | 231 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.27e-07 | 191 | 231 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 7.60e-07 | 192 | 231 | 9 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | E15.5-Mesenchymal|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.93e-07 | 193 | 231 | 9 | 22a9f5b61f197757f72840b9cb849cdb20430e72 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-07 | 193 | 231 | 9 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-07 | 193 | 231 | 9 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-07 | 194 | 231 | 9 | 5099e6ad7c19e5f8b73449d904aaefd97f1b1959 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-07 | 194 | 231 | 9 | 71734ef7b34ab33b349595368176fa0e1175d4d0 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 8.28e-07 | 194 | 231 | 9 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.64e-07 | 195 | 231 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.02e-07 | 196 | 231 | 9 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-07 | 196 | 231 | 9 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-07 | 196 | 231 | 9 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-07 | 197 | 231 | 9 | cc494a656db868bb489238a5becc31bc8518f3cc | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.81e-07 | 198 | 231 | 9 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 9.81e-07 | 198 | 231 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 199 | 231 | 9 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 152 | 231 | 8 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 152 | 231 | 8 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-06 | 156 | 231 | 8 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.69e-06 | 157 | 231 | 8 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.49e-06 | 173 | 231 | 8 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.49e-06 | 179 | 231 | 8 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 4.49e-06 | 179 | 231 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.68e-06 | 180 | 231 | 8 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.79e-06 | 128 | 231 | 7 | 3ca9ae69fb8cb7f8acb7540aa71778bc917da4df | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.88e-06 | 181 | 231 | 8 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-06 | 184 | 231 | 8 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-06 | 184 | 231 | 8 | c350504bfe0ec31cd2fc2199de9b5fff151a8c5e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.73e-06 | 185 | 231 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-06 | 186 | 231 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 186 | 231 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-06 | 187 | 231 | 8 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 6.20e-06 | 187 | 231 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.20e-06 | 187 | 231 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 6.44e-06 | 188 | 231 | 8 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 6.44e-06 | 188 | 231 | 8 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-06 | 188 | 231 | 8 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-06 | 189 | 231 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-06 | 189 | 231 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-06 | 189 | 231 | 8 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 6.70e-06 | 189 | 231 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.70e-06 | 189 | 231 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.96e-06 | 190 | 231 | 8 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.96e-06 | 190 | 231 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 190 | 231 | 8 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.96e-06 | 190 | 231 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 190 | 231 | 8 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 231 | 8 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 231 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.23e-06 | 191 | 231 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 231 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-06 | 192 | 231 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-06 | 192 | 231 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.52e-06 | 192 | 231 | 8 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.11e-06 | 194 | 231 | 8 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.11e-06 | 194 | 231 | 8 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.42e-06 | 195 | 231 | 8 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-06 | 195 | 231 | 8 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.42e-06 | 195 | 231 | 8 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 196 | 231 | 8 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 196 | 231 | 8 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.74e-06 | 196 | 231 | 8 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.74e-06 | 196 | 231 | 8 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 196 | 231 | 8 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.74e-06 | 196 | 231 | 8 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.07e-06 | 197 | 231 | 8 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 198 | 231 | 8 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.41e-06 | 198 | 231 | 8 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.76e-06 | 199 | 231 | 8 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.76e-06 | 199 | 231 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.76e-06 | 199 | 231 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.76e-06 | 199 | 231 | 8 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.76e-06 | 199 | 231 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | CEL ESR1 MEF2D ZMIZ2 AGFG2 UNKL MBD2 POM121L2 POU2F2 CHD7 NUP214 MEGF8 | 6.85e-07 | 196 | 227 | 12 | 3732_UP |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | ZBTB38 ZNF236 UBAP2L SMPDL3A AGFG2 FBRS RANBP9 TSKU COL18A1 NECAP2 ZFHX3 IFI6 | 7.63e-07 | 198 | 227 | 12 | 5298_DN |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | NR2F6 CEL ATP10B ZNF236 MEF2D ACAN ZMIZ2 AGFG2 NUP214 AATK IFI6 | 4.67e-06 | 196 | 227 | 11 | 3742_UP |
| Drug | Hycanthone [3105-97-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | NR2F6 MEF2D CDR2L ACAN ALDH2 TBX2 TCF3 ICAM1 EGR1 DUSP10 IFI6 | 4.67e-06 | 196 | 227 | 11 | 4630_UP |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.14e-06 | 198 | 227 | 11 | 3289_UP | |
| Drug | AC1O43PA | 8.91e-06 | 14 | 227 | 4 | CID006323294 | |
| Drug | Vitamin K 3 | MTA2 ILF2 IRX5 PPRC1 AQP11 ESR1 LRFN3 TSC22D2 ADCY3 GLCCI1 CABLES1 ZNF462 SMPDL3A ALDH2 HSD17B4 GTPBP3 MBD2 TBX2 MAGED1 FLVCR1 HGSNAT RANBP9 NUDT22 TACC2 HIF3A EGR1 MDC1 SMARCC2 ZFHX3 | 2.03e-05 | 1249 | 227 | 29 | ctd:D024483 |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.53e-05 | 193 | 227 | 10 | 4676_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.53e-05 | 193 | 227 | 10 | 4846_UP | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 2.65e-05 | 194 | 227 | 10 | 6380_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 2.89e-05 | 196 | 227 | 10 | 4570_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | ZSWIM8 TSC22D2 AHDC1 AP1B1 CASKIN2 PLAGL1 MZF1 SMARCC2 DUSP10 PRLR | 2.89e-05 | 196 | 227 | 10 | 6227_DN |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.02e-05 | 197 | 227 | 10 | 3786_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | NR2F6 TNRC6B CASKIN2 ZMIZ2 HSF1 TCF3 ASAP3 PLEKHG6 IFI6 GAB1 | 3.15e-05 | 198 | 227 | 10 | 4498_DN |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.15e-05 | 198 | 227 | 10 | 4525_UP | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; ssMCF7; HG-U133A | 3.15e-05 | 198 | 227 | 10 | 376_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 3.15e-05 | 198 | 227 | 10 | 2345_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A | 3.29e-05 | 199 | 227 | 10 | 5749_UP | |
| Disease | obesity (implicated_via_orthology) | ESR1 SEC16A ALDH2 HSD17B4 NOTCH3 TCF3 SIRT1 LIPC DCHS1 ZFHX2 ZFHX3 | 6.53e-07 | 215 | 218 | 11 | DOID:9970 (implicated_via_orthology) |
| Disease | Congenital small ears | 1.27e-05 | 41 | 218 | 5 | C0152423 | |
| Disease | vital capacity | AHI1-DT ZBTB38 PRSS16 ESR1 ADCY3 CABLES1 ACAN ALDH2 COL6A3 TBX4 TCF20 PCDHA13 PCDHA12 PCDHA11 POM121L2 PCDHA10 CHD7 MTF1 VRTN ZFHX3 DUSP10 MYO16 NPAS4 GAB1 | 1.66e-05 | 1236 | 218 | 24 | EFO_0004312 |
| Disease | tooth agenesis (implicated_via_orthology) | 5.43e-05 | 2 | 218 | 2 | DOID:0050591 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 5.95e-05 | 29 | 218 | 4 | EFO_0008009 | |
| Disease | cryptorchidism (biomarker_via_orthology) | 6.28e-05 | 11 | 218 | 3 | DOID:11383 (biomarker_via_orthology) | |
| Disease | body weight | ZBTB38 ESR1 ANKS1B TNRC6B TSC22D2 GLCCI1 BRAP MEX3A ACAN ZMIZ2 TAL1 MAML3 PTBP3 CACNA1C TBX4 TENT4A POM121L2 CHD7 HIF3A LIPC AATK EGR1 ZFHX3 | 6.55e-05 | 1261 | 218 | 23 | EFO_0004338 |
| Disease | body fat percentage | ZBTB38 ANKS1B TDRG1 TSC22D2 ADCY3 ACAN TAL1 MAML3 IGF2BP1 ZFHX3 TNKS SSH2 HR | 7.68e-05 | 488 | 218 | 13 | EFO_0007800 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | ZBTB38 TSC22D2 ADCY3 ACAN TAL1 MAML3 IGF2BP1 ZFHX3 TNKS SSH2 HR | 9.16e-05 | 364 | 218 | 11 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | Hypodontia | 1.36e-04 | 14 | 218 | 3 | C0020608 | |
| Disease | Developmental absence of tooth | 1.62e-04 | 3 | 218 | 2 | C0399352 | |
| Disease | Tooth Agenesis, Familial | 1.62e-04 | 3 | 218 | 2 | C3489529 | |
| Disease | Limb Deformities, Congenital | 2.51e-04 | 17 | 218 | 3 | C0206762 | |
| Disease | alpha-L-iduronidase measurement | 2.51e-04 | 17 | 218 | 3 | EFO_0020139 | |
| Disease | diastolic blood pressure, alcohol drinking | 2.51e-04 | 118 | 218 | 6 | EFO_0004329, EFO_0006336 | |
| Disease | neutrophil measurement | 3.62e-04 | 177 | 218 | 7 | EFO_0803548 | |
| Disease | Male sterility | 4.37e-04 | 48 | 218 | 4 | C0917731 | |
| Disease | Male infertility | 4.37e-04 | 48 | 218 | 4 | C0021364 | |
| Disease | Subfertility, Male | 4.37e-04 | 48 | 218 | 4 | C0848676 | |
| Disease | Global developmental delay | 4.77e-04 | 133 | 218 | 6 | C0557874 | |
| Disease | sexual dimorphism measurement | TTC39B ZBTB38 PRSS16 VGLL2 ESR1 ADCY3 CABLES1 GGT7 ZNF462 ACAN SEC16A NLRC5 TBX4 POM121L2 LIPC ZFHX3 TNKS PRDM6 NPAS4 | 5.99e-04 | 1106 | 218 | 19 | EFO_0021796 |
| Disease | neutrophil count | CEL RIPOR3 GLCCI1 MEF2D CABLES1 SALL1 NLRC5 PLAGL1 MBD2 FLVCR1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 CHD7 POU5F1 SIRT1 AATK PRCC UHMK1 AKAP13 SSH2 | 6.21e-04 | 1382 | 218 | 22 | EFO_0004833 |
| Disease | Colorectal Carcinoma | SALL3 GALNS CSMD3 CABLES1 MYLK3 ALDH2 AMTN TCF3 ASAP3 TRIM28 DCHS1 VRTN MMRN2 HR | 7.85e-04 | 702 | 218 | 14 | C0009402 |
| Disease | monocyte count | CDX2 RIPOR3 ZFPM1 TNFRSF10A AHDC1 MEF2D CABLES1 ZMIZ2 NLRC5 PLAGL1 MN1 TCF3 ICAM1 POU2F2 POU5F1 UHMK1 AKAP13 ELN SSH2 PAN3 MYO16 | 8.33e-04 | 1320 | 218 | 21 | EFO_0005091 |
| Disease | Atherosclerosis | 9.60e-04 | 59 | 218 | 4 | C0004153 | |
| Disease | Atherogenesis | 9.60e-04 | 59 | 218 | 4 | C1563937 | |
| Disease | neuroticism measurement, cognitive function measurement | ANKS1B TSC22D2 ADCY3 ZMIZ2 CACNA1C PCDHA13 PCDHA12 PCDHA11 PCDHA10 IGF2BP1 AATK ZFHX3 | 1.10e-03 | 566 | 218 | 12 | EFO_0007660, EFO_0008354 |
| Disease | focal segmental glomerulosclerosis (implicated_via_orthology) | 1.11e-03 | 7 | 218 | 2 | DOID:1312 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.14e-03 | 157 | 218 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Cerebrovascular accident | 1.16e-03 | 62 | 218 | 4 | C0038454 | |
| Disease | breast carcinoma (is_marker_for) | 1.46e-03 | 66 | 218 | 4 | DOID:3459 (is_marker_for) | |
| Disease | LEUKEMIA, ACUTE LYMPHOBLASTIC | 1.48e-03 | 8 | 218 | 2 | 613065 | |
| Disease | Acute lymphoid leukemia | 1.48e-03 | 8 | 218 | 2 | cv:C0023449 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.53e-03 | 31 | 218 | 3 | EFO_0022249 | |
| Disease | Uterine leiomyoma, breast carcinoma | 1.68e-03 | 32 | 218 | 3 | EFO_0000305, HP_0000131 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.72e-03 | 69 | 218 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | melanoma (is_marker_for) | 1.84e-03 | 33 | 218 | 3 | DOID:1909 (is_marker_for) | |
| Disease | pseudoxanthoma elasticum (is_implicated_in) | 1.89e-03 | 9 | 218 | 2 | DOID:2738 (is_implicated_in) | |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 1.89e-03 | 9 | 218 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | ulcerative colitis (biomarker_via_orthology) | 1.89e-03 | 9 | 218 | 2 | DOID:8577 (biomarker_via_orthology) | |
| Disease | acoustic startle blink response measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0006875 | |
| Disease | Intellectual Disability | ZNF462 PRR12 AP1B1 NRXN2 MN1 TCF20 GRIN2D COL18A1 MTF1 SMARCC2 | 1.92e-03 | 447 | 218 | 10 | C3714756 |
| Disease | carbohydrate intake measurement | 2.01e-03 | 34 | 218 | 3 | EFO_0010811 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 2.01e-03 | 34 | 218 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | executive function measurement | 2.03e-03 | 376 | 218 | 9 | EFO_0009332 | |
| Disease | neutrophil percentage of leukocytes | ZBTB38 CEL TNRC6B GLCCI1 BRAP NLRC5 PLAGL1 MFSD2B CHD7 SEC31A AATK AKAP13 | 2.06e-03 | 610 | 218 | 12 | EFO_0007990 |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 2.24e-03 | 123 | 218 | 5 | EFO_0007789, EFO_0008002 | |
| Disease | tooth agenesis (is_implicated_in) | 2.35e-03 | 10 | 218 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.35e-03 | 10 | 218 | 2 | EFO_1000650, HP_0000131 | |
| Disease | hip bone mineral density | 2.49e-03 | 126 | 218 | 5 | EFO_0007702 | |
| Disease | Schizophrenia | AHI1-DT PRSS16 ESR1 BRAP NRXN2 MBD2 CACNA1C ICAM1 RANBP9 GRIN2D SIRT1 NPTN UHMK1 MYO16 NPAS4 | 2.49e-03 | 883 | 218 | 15 | C0036341 |
| Disease | free cholesterol to total lipids in large VLDL percentage | 2.57e-03 | 37 | 218 | 3 | EFO_0022281 | |
| Disease | breast cancer (is_marker_for) | 2.60e-03 | 185 | 218 | 6 | DOID:1612 (is_marker_for) | |
| Disease | mean reticulocyte volume | PPRC1 TRO ZFPM1 BRAP AGFG2 MBD2 TAL1 MN1 SLC27A5 EP400 RFC1 IDUA AKAP13 MYO16 | 2.62e-03 | 799 | 218 | 14 | EFO_0010701 |
| Disease | systolic blood pressure, alcohol drinking | 2.67e-03 | 128 | 218 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | aortic measurement | 2.74e-03 | 251 | 218 | 7 | EFO_0020865 | |
| Disease | choline measurement | 2.85e-03 | 130 | 218 | 5 | EFO_0010116 | |
| Disease | Diabetic Retinopathy | 2.86e-03 | 11 | 218 | 2 | C0011884 | |
| Disease | pancreatitis (biomarker_via_orthology) | 2.99e-03 | 39 | 218 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | smoking cessation | 3.01e-03 | 325 | 218 | 8 | EFO_0004319 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.38e-03 | 195 | 218 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Oligodontia | 3.42e-03 | 12 | 218 | 2 | C4082304 | |
| Disease | metabolite measurement, body weight gain | 3.42e-03 | 12 | 218 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | waist-hip ratio, body mass index | 3.42e-03 | 12 | 218 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | disks large homolog 3 measurement | 3.42e-03 | 12 | 218 | 2 | EFO_0802472 | |
| Disease | serum gamma-glutamyl transferase measurement | ZFPM1 TNFRSF10A CSMD3 POM121 SALL1 ZMIZ2 ALDH2 TAL1 BICRA DNAJC30 ICAM1 ASAP3 NPTN NECAP2 AKAP13 | 3.44e-03 | 914 | 218 | 15 | EFO_0004532 |
| Disease | Diaphragmatic Hernia | 3.45e-03 | 41 | 218 | 3 | C0019284 | |
| Disease | epilepsy | 3.45e-03 | 41 | 218 | 3 | EFO_0000474 | |
| Disease | pulse pressure measurement | ESR1 TNRC6B TSC22D2 AHDC1 AREL1 NOTCH3 TBX2 COL6A3 WNT9B PCDHA13 PCDHA12 PCDHA11 PCDHA10 MEGF8 MTF1 ABI2 AKAP13 ZFHX3 ELN PRDM6 | 3.60e-03 | 1392 | 218 | 20 | EFO_0005763 |
| Disease | lipoprotein measurement, phospholipid measurement | 3.68e-03 | 85 | 218 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | ascending aortic diameter | 3.91e-03 | 140 | 218 | 5 | EFO_0021787 | |
| Disease | visceral adipose tissue measurement, body mass index | 4.00e-03 | 87 | 218 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | velocity of sound measurement | 4.02e-03 | 13 | 218 | 2 | EFO_0005654 | |
| Disease | Migraine Disorders | 4.02e-03 | 13 | 218 | 2 | C0149931 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 4.02e-03 | 13 | 218 | 2 | C0238288 | |
| Disease | putamen volume change measurement | 4.02e-03 | 13 | 218 | 2 | EFO_0021495 | |
| Disease | hypothyroidism (implicated_via_orthology) | 4.02e-03 | 13 | 218 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Congenital Heart Defects | 4.21e-03 | 44 | 218 | 3 | C0018798 | |
| Disease | diastolic blood pressure, systolic blood pressure | VGLL2 ESR1 TNRC6B ACAN SEC16A TAL1 CACNA1C RANBP9 MMRN2 ZFHX3 ELN PRDM6 | 4.37e-03 | 670 | 218 | 12 | EFO_0006335, EFO_0006336 |
| Disease | silicosis (biomarker_via_orthology) | 4.66e-03 | 14 | 218 | 2 | DOID:10325 (biomarker_via_orthology) | |
| Disease | Impaired cognition | 4.66e-03 | 14 | 218 | 2 | C0338656 | |
| Disease | myocardial infarction | 4.69e-03 | 350 | 218 | 8 | EFO_0000612 | |
| Disease | intraocular pressure measurement | TSC22D2 CWC25 GLCCI1 BRAP COL6A3 WNT9B ISOC1 CSPG4 AKAP13 ZFHX3 | 4.81e-03 | 509 | 218 | 10 | EFO_0004695 |
| Disease | Calcium channel blocker use measurement | 5.18e-03 | 213 | 218 | 6 | EFO_0009930 | |
| Disease | Alopecia, Male Pattern | 5.35e-03 | 15 | 218 | 2 | C4083212 | |
| Disease | hepatoblastoma (is_marker_for) | 5.35e-03 | 15 | 218 | 2 | DOID:687 (is_marker_for) | |
| Disease | African Burkitt's lymphoma | 5.35e-03 | 15 | 218 | 2 | C0343640 | |
| Disease | tumor necrosis factor measurement | 5.35e-03 | 15 | 218 | 2 | EFO_0010834 | |
| Disease | body weights and measures, body height | 5.35e-03 | 15 | 218 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | response to olanzapine | 5.35e-03 | 15 | 218 | 2 | GO_0097333 | |
| Disease | Androgenetic Alopecia | 5.35e-03 | 15 | 218 | 2 | C0162311 | |
| Disease | Burkitt Leukemia | 5.35e-03 | 15 | 218 | 2 | C4721444 | |
| Disease | Female pattern alopecia (disorder) | 5.35e-03 | 15 | 218 | 2 | C0263477 | |
| Disease | phosphatidylcholine measurement | 5.36e-03 | 284 | 218 | 7 | EFO_0010226 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 5.71e-03 | 49 | 218 | 3 | EFO_0022256 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 6.04e-03 | 50 | 218 | 3 | C0023453 | |
| Disease | cerebellum white matter volume change measurement | 6.09e-03 | 16 | 218 | 2 | EFO_0021498 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 6.38e-03 | 51 | 218 | 3 | EFO_0022285 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 6.74e-03 | 52 | 218 | 3 | C0023452 | |
| Disease | Hypermetropia | 7.25e-03 | 103 | 218 | 4 | HP_0000540 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPAAAGGAGLQPLAS | 241 | Q96L91 | |
| SPVPAGFGFSAAAGE | 16 | Q7Z569 | |
| GGLNGAAAPNPASLS | 901 | P55198 | |
| ASRAAGFPAGQVPGS | 1346 | Q5SNV9 | |
| GPAATAAAEQLSPGG | 146 | Q99626 | |
| ALSSAFLGEPSAGPG | 396 | Q8TDY4 | |
| LGAQDGVSSPAASPG | 296 | Q86X02 | |
| TGLLPGSIFAPSGAN | 111 | Q9NXE8 | |
| SDFSGVILSPGFPGN | 2116 | Q7Z407 | |
| DGFLNASSAVPGAPL | 126 | Q6UVK1 | |
| GAPAPGSGATIFALS | 26 | Q969Y2 | |
| GGAAQSLVPPGASLA | 1011 | Q12802 | |
| AAGPTGGASRLHPNA | 21 | Q9BZ19 | |
| AAAAASLGSLPGPGA | 86 | Q86VQ1 | |
| AVPANLGAPIGSGLS | 686 | Q10567 | |
| LFPGGILPTSQAGAN | 131 | Q6UX39 | |
| GACPGALRPQAGASF | 156 | P0C7V0 | |
| GSSGAGADPSFQPVL | 901 | Q5TGY3 | |
| GPLGFLSTGDANLPG | 166 | P19835 | |
| SPAAAAALIFPGGSG | 36 | Q6ZP65 | |
| NGSVGAATAPAGLPS | 2871 | Q9P2D1 | |
| GSNLSFGPGAKRPAQ | 281 | A6NDY2 | |
| FFSVGASGGPQAAAP | 901 | Q2TAZ0 | |
| PDANGSFLPSALGGF | 351 | O94823 | |
| PNAAAGGAPNLADGF | 316 | Q9NYB9 | |
| GGAPTPALVAGSSAA | 116 | Q96S59 | |
| AGAGVPFSANGRPLA | 566 | O94776 | |
| PPGSALAAVASGGDL | 146 | P10588 | |
| LAAVASGGDLFPGQP | 151 | P10588 | |
| IAGQALGGSRASPAP | 366 | P78411 | |
| GSNLSFGPGAKRPAQ | 281 | A6NKC0 | |
| ESLLGGPGGASAAPA | 116 | Q9Y2U8 | |
| AVALDLPGFGNSAPS | 126 | Q9BUJ0 | |
| DPGQFAGLLHGSSPA | 601 | Q7Z6G8 | |
| GSNLSFGPGAKRPAQ | 281 | A8MXZ1 | |
| APALLATQAGSAGGA | 561 | Q9Y5I1 | |
| FLQASGAAGGGLPIQ | 1211 | Q96JQ0 | |
| VSQAFPTLAGPGGLF | 171 | Q96DN6 | |
| GQAPNGLPAVGSFVS | 256 | P55771 | |
| GIQGAQLPSSGVFSP | 341 | A8MTJ6 | |
| AGGAGAPSGTVPVLF | 16 | Q96CN7 | |
| PGSLPSGQDSFLGQL | 11 | P31267 | |
| FASQGAPAGLGEPQL | 221 | O75610 | |
| GGLGPPFAFNLNSDT | 206 | Q14676 | |
| AGPIIGPGGTASANF | 751 | Q9Y5V3 | |
| GPGAPLSGSVLAEAA | 11 | Q9UPQ8 | |
| TGAPGAVTTLAAGQP | 111 | Q9UGP4 | |
| AGGSFPGLPDGADLV | 1101 | Q96JK9 | |
| QGSPTGAALGSPALL | 286 | Q9BRQ3 | |
| DRPASPGLALFNGSG | 1551 | Q9Y6X6 | |
| ADEIPAATFGLGGAP | 641 | Q5IJ48 | |
| GSNLSFGPGAKRSAP | 281 | Q86YD7 | |
| APGTNGSLVLATPGA | 346 | Q9H8L6 | |
| PNLFGSNSLDGGSSP | 601 | Q13480 | |
| PGLNLAAVGLFPASS | 366 | Q9NZI8 | |
| LSPAVPFSGTIQGGL | 11 | Q6DKI2 | |
| TNGAGTGAAQAPALP | 586 | Q9P244 | |
| KGANASNPGPFGDVL | 66 | Q92484 | |
| LSPAVPFSGTIQGGL | 11 | Q3B8N2 | |
| LSPAVPFSGTIQGGL | 11 | O00182 | |
| QPGPLSQAGSAGVAA | 6 | Q96EX3 | |
| RSFSGGQLASGPDPA | 196 | Q9NRD8 | |
| VGGGASAASSLLPQP | 296 | Q9Y6W6 | |
| LSNGAPQFLGAAGAP | 41 | P18146 | |
| PQFLGAAGAPEGSGS | 46 | P18146 | |
| LAAAEPGLFGLNSGG | 221 | O43593 | |
| GSNLSFGPGAKRPAQ | 281 | P0C7W9 | |
| GPGAAGPSNVPAFLT | 6 | Q00613 | |
| AAAFGSNGLGGFPPL | 86 | P03372 | |
| SLNQPFGSGLITPSG | 491 | Q9UJ14 | |
| PSLEVAPGAGQGASS | 276 | Q32MK0 | |
| GSIFSPDGGALGPAQ | 1181 | P39060 | |
| SSPVPGELGLAGALF | 511 | Q8IX07 | |
| DGATGAPGVLFAPSA | 1541 | Q9P2S2 | |
| PGAFLPGLKAAQSGS | 2046 | Q9UM47 | |
| SARIGAAGAFLSPPG | 226 | Q7Z7M0 | |
| NQLSSPSLGFDGLPG | 281 | P09086 | |
| TGLDAAGPLFEGSAP | 191 | P11150 | |
| DLGPAAGNPALSFGL | 41 | P12525 | |
| SLLPAGGAPTVFSFG | 471 | P35658 | |
| FSSPNKTGGFGAAPV | 1961 | P35658 | |
| APGGSFRALEAAPGL | 276 | A6NIK2 | |
| PPALDGSLGDGSSGF | 1146 | Q9ULI4 | |
| APASGPGLSFLAGLS | 261 | A6NFX1 | |
| GSPASALVLAFGGNP | 236 | Q9BTN0 | |
| GSNLSFGPGAKRPAQ | 281 | P0DV74 | |
| AGLAGVGAFPAALPA | 256 | Q9UNW9 | |
| GSNLSFGPGAKRPAQ | 281 | P0DV73 | |
| GPATAGPRLLTFQGS | 656 | Q8WXE0 | |
| LLAFGVASATPGPAA | 1006 | Q8WXE0 | |
| GSNLSFGPGAKRPAQ | 281 | P0DV76 | |
| PFSHLGPGGALSLAQ | 1696 | Q86WI3 | |
| NFADGAPSAPGTANG | 131 | Q5XG87 | |
| GLFGVSGQPSGFPDT | 1731 | P16112 | |
| AGSPFSGGPVSFPLA | 301 | Q01860 | |
| GGFQPESTPSLDAGL | 626 | Q86Y26 | |
| NAPALLTPGAGSAGG | 561 | Q9Y5I0 | |
| APALLASPAGSAGGA | 561 | Q9Y5I2 | |
| APAQGFVGVAPFGSA | 791 | A6NF01 | |
| AAGSSVFPGLLSLPG | 861 | Q86XN7 | |
| KGSGAAGLLSAPQPL | 36 | Q9NQX0 | |
| PAAGAAPGLGLHSNS | 71 | Q58A45 | |
| SIAFPAIGTGNLGFP | 1126 | Q460N5 | |
| AFGAPASSQPAFGGS | 1046 | Q96HA1 | |
| APAQGFVGVAPFGSA | 1206 | Q96HA1 | |
| ASGQPLDPIGLQSGF | 236 | Q3KR16 | |
| GSNLSFGPGAKRPAQ | 281 | A6NJQ4 | |
| AIEQGGQGSALAPSP | 31 | Q9UBB5 | |
| FAGGTPLAGPTGLLS | 56 | Q8IUM7 | |
| SGSLASNPAPFPAGA | 76 | P0CG12 | |
| AALISAPEQGGSNGP | 291 | P34059 | |
| SALDFLAGPGSLGGA | 6 | O14976 | |
| LGDLSSGLQGSPAGF | 1086 | O14976 | |
| GLPPAVSFGSLQGAF | 31 | Q9HAH7 | |
| AAAGPFPAPLNGSSQ | 181 | Q96RP8 | |
| SGGAPQSPNGALLPF | 2166 | Q13936 | |
| ALAAPGTPAAGLAAG | 121 | Q8TDN4 | |
| VAGLGVPGSPSFLNG | 491 | Q9BQW3 | |
| PAAPGFGNLGKSFLI | 26 | Q6ZNG2 | |
| RAPAAALASAPGLGG | 16 | P07954 | |
| ALASAPGLGGAAVPS | 21 | P07954 | |
| TSGFAGAIGQKLPPF | 321 | P51659 | |
| LGGPTPNTGAALEFV | 1101 | P12111 | |
| AAGLFLPGSVGITDP | 276 | Q12905 | |
| LPALGFTGAGIAANS | 56 | P09912 | |
| AQPAGATAFGGFSQP | 61 | P35452 | |
| NGLNGSALPNGAPAS | 506 | O60266 | |
| LLQFTTGSSQLPPGG | 751 | O15033 | |
| TGSSQLPPGGFAALC | 756 | O15033 | |
| SLAAASGVLGGPQTP | 56 | Q9Y5Y0 | |
| ADPALGSLPAAGLSG | 101 | P0C7T7 | |
| AASPALRLGGPGDSF | 211 | P35475 | |
| FASQGAPAGLGEPQL | 221 | O00292 | |
| CLFGPLQAGPSNAGG | 191 | Q9ULV5 | |
| AGGSGPAISRLQAAP | 176 | Q12952 | |
| LAPGGSSGRDAQAAP | 51 | Q68CP4 | |
| LLGALFPGPGNAQTS | 16 | P05362 | |
| LASGTISGPEPENFG | 346 | P16930 | |
| GFPTAAPGAESGLSL | 251 | A6NMB9 | |
| RGFPQNSAPSLGLGA | 21 | Q96LL9 | |
| GPSPLAASPAFLGQG | 176 | Q1W209 | |
| LGVPGSPGFLNGSSA | 501 | Q9H4W6 | |
| FAPAGATLTIQGEPG | 371 | Q9NZM4 | |
| GAGLGAFPAVTFPGA | 76 | P15502 | |
| TFPGALVPGGVADAA | 86 | P15502 | |
| GSNLSFGPGAKRPAQ | 281 | A8MXJ8 | |
| LDSGTLPPAVAAAGG | 541 | Q9H4Q3 | |
| FANGLSPTPVNGGAL | 956 | Q9NSC2 | |
| LSAGAPAAAIAGSGP | 266 | Q9BXA9 | |
| AGSGPAAPAAFEGAQ | 276 | Q9BXA9 | |
| PAPADSLAVGNSGGV | 1191 | Q5VV67 | |
| GSNLSFGPGAKRPAQ | 281 | P0C7X0 | |
| PSFSIENIIGGGPAA | 376 | Q9UJU5 | |
| LGGDLNSANGACPSP | 206 | Q14814 | |
| QPSLGVSFGTPFGSG | 481 | Q9BVL2 | |
| NAPALLATPAGSAGG | 561 | Q9UN75 | |
| GTPQPAGLASGAKLA | 186 | O96013 | |
| QLQSPGAGVGLPSAA | 711 | Q10571 | |
| ATSALGGQPGFPFGA | 736 | Q10571 | |
| VSGLGFGASLLPQGF | 211 | Q12947 | |
| LSPSLSPLGGQAAGA | 106 | Q9Y261 | |
| GNAPAGALGAASESP | 6 | Q6ZN16 | |
| GGLAPLPSAGDLFST | 311 | Q9NQG5 | |
| PFPLGASAQNGLASS | 241 | Q9UM63 | |
| SGAPAPAGISGSDLQ | 571 | Q3ZLR7 | |
| IASSAFPGLGSLGGQ | 66 | Q3Y452 | |
| AVAPTSGPALGGLFA | 26 | Q92733 | |
| TAVALGSFPAGGPAE | 36 | Q9H6Q3 | |
| ATLGNVSAGPSPAGL | 26 | P32745 | |
| GPQLAGSSAGPVTAA | 136 | O75157 | |
| ILATGSTGPFPGKFN | 106 | Q9BRQ8 | |
| EGNSSEFQGPPGLLS | 1111 | Q6ZMQ8 | |
| FGLSFPLGGPAAVAA | 251 | P28360 | |
| PLGGPAAVAAAAGAS | 256 | P28360 | |
| GSSFKAALLSGPPGV | 641 | P35251 | |
| SQPLASLGSGFFGEP | 141 | P17542 | |
| APSLGPGSQQAAFGN | 446 | Q14872 | |
| GSNLSFGPGAKRPAQ | 281 | A8MX19 | |
| SFLLTGGPAPGSLQD | 611 | Q9Y2N7 | |
| TGVGAVPLPASGNSF | 361 | Q9UL41 | |
| GSNLSFGPGAKRPAQ | 281 | A6NNJ1 | |
| GSNLSFGPGAKRPAQ | 281 | P0C7W8 | |
| GSNLSFGPGAKRPAQ | 281 | D6RGX4 | |
| PQGGLPSSKLDSGFA | 2486 | Q7Z333 | |
| ALALQPGGSPSAAGA | 6 | Q96EB6 | |
| GASTPPTLGDLFAGG | 91 | A6NGB9 | |
| SATPAAPAGPFAGSQ | 366 | P57073 | |
| PPSGAFGLGGALEAA | 1336 | Q9ULL5 | |
| GPAGISFLGNSAPVS | 601 | Q9Y2I6 | |
| SLPLGPGLGSAAAQS | 1156 | Q8TAQ2 | |
| GSNLSFGPGAKRPAQ | 281 | P0C7V4 | |
| SGIGGIPAGFPISQA | 846 | Q96KW2 | |
| NIVPGFGPTAGAAIA | 236 | P05091 | |
| PNSLADVGSFLGPGV | 311 | O95081 | |
| AGGSLTGAVFNPALA | 206 | Q8NBQ7 | |
| SALGPGAGAAQPSAS | 16 | Q96FZ5 | |
| GAGAAQPSASPLEGL | 21 | Q96FZ5 | |
| GAFILGAGAGPFQTL | 91 | Q9H0W9 | |
| LSCTLPNGFGGQSGP | 241 | Q9H4L4 | |
| GPAGPAAQQAAKLFG | 481 | O15417 | |
| FSQPGALGNTPPFLG | 106 | Q7Z739 | |
| SPLVQASGGPLACFG | 596 | Q7RTX0 | |
| GGSAGPSPFALLCAG | 26 | Q5VTQ0 | |
| GTPAASFNLPSALGS | 1001 | Q14157 | |
| SFNLPSALGSGGPIN | 1006 | Q14157 | |
| SALGSGGPINPATAA | 1011 | Q14157 | |
| LAPFNSGPAASSGLL | 2241 | Q9C0A1 | |
| PFASPSGDVAQGLGL | 286 | Q8N8G2 | |
| KAGSALPGFANSPAG | 946 | O15027 | |
| GAALFLPRGNGSSTP | 46 | Q76I76 | |
| NLGGESPSLPQGSLF | 471 | Q96MK2 | |
| GAPITNPGFGGAFST | 1091 | Q12816 | |
| RPASLAGAQFGGSGL | 36 | P15923 | |
| SASPLGAGHLPGLAF | 456 | Q13207 | |
| GQAGAAGPLGAIPSS | 1021 | O95428 | |
| SPTPGVGALGAALDA | 256 | Q9Y2P5 | |
| LAAFPSLGAGGETPE | 11 | Q8TB61 | |
| ASEGEPLFAGGSAIP | 521 | Q9UQR0 | |
| GAAFGVAPALPGQVT | 211 | A1L020 | |
| NFIPNAPGDSAAAGG | 561 | A7XYQ1 | |
| GAADAPGLLGVPSNA | 21 | Q8WZ71 | |
| GPLRGSSGAQATFPQ | 306 | O43278 | |
| AAGVSSTAPLGPGAA | 156 | O95271 | |
| LVSGSLLPGPGAAQN | 16 | Q9Y639 | |
| VGPAGAPATLLNEAG | 441 | P16471 | |
| LALGLTATFPGEPGA | 826 | Q96DN2 | |
| PKLLASFPSAGEQGG | 1111 | O95359 | |
| QDPFGGNPFTALLAG | 286 | Q8IYU4 | |
| PSPNSHAAGFKGFGL | 426 | Q9UGU0 | |
| AGAAGFAPAIGFPQA | 306 | O95758 | |
| GAFLAVTPNPGSAAS | 11 | O00220 | |
| LGAAGPRSLAGSAPV | 446 | Q9H9P5 | |
| GQGSSFLGPGTFPES | 746 | Q8NF64 | |
| GALQPLTSGSAGPAQ | 1051 | A7E2V4 | |
| PGSGEAGVSFDLPAQ | 1006 | Q641Q2 | |
| STPVARGGGLPATFN | 991 | Q96JM2 | |
| FPALLTDPSLSGQGG | 1596 | Q9UL36 | |
| PLPLGASAQGSSLGQ | 51 | O43247 | |
| EPALAAPGLSGAALG | 31 | P57082 | |
| GQNGGSFTGPEPLLS | 416 | Q8NAP3 | |
| FPGLGTAAAPAQGGA | 36 | O14905 | |
| SGPLLSQPVVAAAGG | 621 | Q9H8Y1 | |
| SSFGNLDPFGTGQPL | 351 | O94979 | |
| AATGQPASGLEAPGS | 6 | Q9NWH2 | |
| SLDGNPLAVIGPGAF | 211 | Q8WUA8 | |
| GAAAGAPGPVSSQNL | 106 | A0A286YF58 | |
| AGSTGLLFNLPPGSV | 196 | Q99990 | |
| SAQGLGLSLGPGAAA | 41 | Q9NQE7 | |
| GALKQFLPPGTTGAA | 51 | Q8TAS1 | |
| AAAGEALVGAAGFPP | 126 | Q9H1B5 | |
| AAAAATGQPGTAPAG | 526 | Q13263 | |
| SDPVGPALNLFGGST | 1756 | Q9UPQ9 | |
| QSGGAFPIANGPNLT | 81 | Q15386 | |
| AGSAAGPEQPQAGLL | 381 | Q15911 | |
| GPSLPALGAGAAAGS | 211 | Q5SQQ9 | |
| GSNLSFGPGAKRPAQ | 281 | P0DV75 | |
| AAGPGPASVSGLAAG | 166 | Q8IYS2 | |
| HTSLGAGGFPAALPA | 2486 | O14686 | |
| SLAGPSGGFFPGNLA | 3691 | O14686 | |
| AGGIFSPGFALQLGS | 251 | P28698 | |
| SPGFALQLGSISAGP | 256 | P28698 | |
| GGAPLPAGLFAVRSA | 296 | O15399 | |
| GSLVQPAVAPSSGGA | 211 | Q9NVZ3 |